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Myeloid-derived suppressor cells (MDSC) are immature myeloid cells which 
accumulate in cancer patients and tumor-bearing mice. Their function in the tumor 
microenvironment is to inactivate the immune response to cancer by suppressing both 
the adaptive and innate immune system. Therefore, MDSC are a major obstacle in 
immunotherapeutic approaches designed to cure cancer. MDSC-derived from tumor 
bearing mice have been found to shed exosomes. Exosomes are nano-sized vesicles 
that carry biologically active molecules and play a role in intercellular 
communication. MDSC-derived exosomes have been reported to mediate the 
immunosuppressive functions of the parental cells by stimulating the accumulation of 
MDSC and also by converting macrophages to a tumor-promoting phenotype.  
Recent developments in government policy have launched a goal of curing 
cancer using immune-based therapies (Cancer MoonShot 2020). The understanding 
  
of the mechanisms and functions of MDSC immune suppression will be crucial in the 
success of these therapeutic endeavors. Our current study focuses on interrogating the 
protein cargo carried by MDSC-derived exosomes based on differential post-
translational modifications (PTMs). Post-translational modifications have important 
roles in functions, signaling, location and interactions of proteins. Selecting proteins 
based on a specific post-translational modification can aid in the identification of low-
abundance proteins, which may not be identified in a shotgun proteomics approach.  
The first aim of this work was to successfully modify an existing surface 
chemistry method to use on exosomes. We then used a proteomic strategy to identify 
glycoproteins on the surface of MDSC-derived exosomes, and then test if selected 
glycoproteins contribute to exosome-mediated chemotaxis and migration of MDSCs. 
Furthermore, we also aimed at examining the ubiquitome of the MDSC-derived 
exosomes, using top-down and bottom-up proteomics. Since inflammation has been 
reported to enhance the tumor promoting activity of the MDSC, the bottom-up 
analysis focused on the effects of increased inflammation on the ubiquitination of the 
protein cargo of MDSC-derived exosomes. Spectral counting was used to estimate 
differences in abundance of proteins found with ubiquitinated proteoforms in high 
and basal levels of inflammation. The top-down analysis aimed at characterizing the 
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Chapter 1: Introduction 
 
1.1. Research significance and objectives 
Exosomes were first discovered in 1983 when transferrin receptors were observed to 
be leaving reticulocytes on vesicles of ~50 nm in diameter.1 The field of exosome research 
has exploded in the last three decades, resulting in over a thousand publications on the topic 
as scientists try to better understand their role in cellular communication. Exosomes have 
been found to be generated by both healthy and cancerous eukaryotic cells. In the realm of 
the tumor microenvironment, most studies have focused on exosomes released by tumor 
cells. 2–5 However, the tumor microenvironment is also composed of several types of cells 
that contribute to tumor-induced immune suppression. This study focuses on one of these 
cellular players: myeloid derived suppressor cells (MDSC) derived exosomes and their role in 
intercellular communication in the tumor microenvironment. They are immature myeloid 
cells that accumulate in the tumor microenvironment. MDSC are immunosuppressive cells 
that aid in tumor progression by suppressing T cell activation and redirecting macrophage 
polarization towards a tumor promoting type, among other functions.6  Exosomes shed by 
MDSC have been found to carry a biologically active cargo of proteins and small RNAs, 
which contribute to their parental cells’ immunosuppressive function.7  
Exosomes are thought to be players in intercellular communication in that they can 
transfer their cargo to cells in their environment. Interacting with a recipient cell is thought to 
involve the binding of a specific exosome receptor to the cell surface followed by endocytosis  
and fusion.8 Surface proteins are known to be involved in a host of important functions 




enriched in plasma membrane proteins,9 but to date an inventory of the surface proteome of 
exosomes has not been carried out. A study of the surface proteome would provide 
identifications of low abundance proteins and allow us to gain insight into potential players in 
communication in the tumor microenvironment.  
The mechanism of biogenesis of exosomes and the sorting of biological cargo in 
exosomes is not well understood. A role for ubiquitination in sorting of proteins into 
exosomes is still disputed and of interest to the scientific community.10 Ubiquitination is a 
post-translational modification (PTM) in which the protein ubiquitin is attached to a substrate 
protein. This PTM can lead to signaling in a host of different pathways including the nuclear 
factor kappa-light-chain enhancer of activated B-cells (NF-κB) pathway, DNA damage 
response, immune inflammation response and proteolytic degradation among others.11 
Therefore, targeting and analyzing the ubiquitin proteome (ubiquitome) is expected to 
provide more insights into the biological relevance of the protein cargo carried by MDSC 
derived exosomes.  Both exosome surface glycoproteins and ubiquitinated proteins are 
studied here using novel proteomic strategies and state-of-the art mass spectrometry.  
 
1.2. Myeloid derived suppressor cells  
Myeloid-derived suppressor cells (MDSC) are immature myeloid cells present in 
cancer patients. MDSC are characterized by marker proteins cluster of differentiation 
molecule (CD) 11b (CD11b) and gamma response 1 (Gr1) in mice and by marker proteins 
CD11b, CD14, CD33, and CD15 in humans. 12 Under normal conditions myeloid cells in 
bone marrow differentiate into macrophages, dendritic cells, and granulocytes.13,14 However, 
in conditions of increased inflammation or cancer, myeloid cells do not differentiate correctly 




is a result of tumor-released factors including reactive oxidation species, nitric oxide and 
cytokines. It has also been demonstrated that inflammation leads to an increase in MDSC 
accumulation and immune suppression function. The proinflammatory cytokines involved in 
MDSC accumulation include but are not limited to interleukin (IL) 1β (IL-1β), IL-6, and 
prostaglandin E2 (PGE2).12 Vascular endothelial growth factor (VEGF) and granulocyte-
macrophage colony-stimulating factor (GM-CSF) stimulate angiogenesis, drive tumor growth 
and are involved in MDSC accumulation.  Tumor-secreted soluble factors also disrupt normal 
cellular functioning by altering activation of transcription factors including signal transducer 
and activator of transcription (STAT) 1, 3 and 6. 12,14    
 
Figure 1.1. Depicts the differentiation of immature myeloid cells to form MDSC or other 
immune cells based on the environment. Adapted from reference 14. 
MDSC’s role in the tumor microenvironment is that of suppressing the adaptive and 
innate immune system. The MDSC target T cells and natural killer cells and suppress their 
activity to promote the growth of the tumor. The mechanisms of their suppressive activity 






L-arginine catabolism which leads to amino acid starvation, induction of regulatory T cells 
and T helper 17 (Th17) cells, and induction of apoptosis.14,15   
A limited number of proteomics studies have been performed on MDSC. Boutte et al. 
compared the proteomes of MDSC from metastatic (murine mammary carcinoma 4T1) and 
non- metastatic (murine mamary carcinoma 67NR) tumors in mice. 16 Ninety-three percent of 
the proteins identified in this study were shared between the two types of MDSC, and the 
study found that the proteins in pathways involved in γ -glutamyl transferase, glutathione 
synthase and cyclic adenosine monophosphate (cAMP) response element-binding protein 
(CREB) transcription factor signaling were up-regulated in 4T1 metastatic MDSC.16 A 
proteomic study by Chornoguz et al. studied the effect of increased inflammation on the 
proteomes of 4T1 MDSC in mice. The 4T1 cells were stably transfected with IL-1β, a 
cytokine that increases inflammation. This study determined that Fas-induced apoptosis, 
TGF- cytokines, and caspase network stress associated pathways were up regulated in 
inflammatory MDSC.17 
Other studies have focused on understanding the role of proteins identified in MDSC.  
A study by Sinha et al. focused on the role of pro-inflammatory cytokines S100 calcium 
binding protein A8 (S100A8) and S100A9, which are found in the tumor microenvironment, 
and their role in MDSC function. MDSC have carboxylated N-glycans on their surface, 
which serve as receptors for S100A8 and S100A9. MDSC were also found to secrete 
S100A8/A9 and activate the inflammatory NF-κβ pathway. In addition this study also 
determined that S100A8/A9 are chemotactic for MDSC, which leads to maintenance of a pro-
inflammatory tumor environment.18 Several proteoforms of S100A8/A9 have been identified 
using top-down proteomics studies in exosomes shed by 4T1-IL1β.19,20 Another protein of 
importance discovered in MDSC is high mobility group box protein 1 (HMGB1). Parker et 




progenitor cells. HMGB1 also plays a role in the functions of MDSC and not just in the 
activation of the MDSC. The protein was found to suppress anti-tumor immunity by 
suppressing antigen driven T-cell activation. It was also found to increase production of     
1L-10, which also drives MDSC-macrophage cross talk. Somewhat surprisingly, HMGB1 
was also found to have some anti-tumor activity due to its ability to activate tumor-reactive T 
cells.21  
         
1.3. Exosomes shed by myeloid derived suppressor cells 
Exosomes are membrane bound extracellular vesicles, 30-100nm in size. They are 
shed from all eukaryotic and many bacteria cells. They are different from microvesicles, 
oncosomes and apoptotic bodies not just in size but also in the method of biogenesis.22 
Exosomes are formed by the inward budding of the plasma membrane to form multivesicular 
bodies (MVBs). The membrane of the multivesicular bodies buds inwardly and forms 
interlumenal vesicles (ILVs).23–25 The formation of the ILV’s is still not well understood and 
is thought to occur by two possible pathways; endosomal sorting complexes required for 
transport (ESCRT) dependent and ESCRT independent.26,27 ESCRT proteins such as Alix, 
and Hepatocyte growth factor–associated tyrosine kinase (Hrs), are shown to be involved in 
sorting of proteins into exosomes.28,29 The ESCRT independent pathway relies on 
sphingomyelinase, an enzyme which produces ceramide.27 The presence of high ceramide 
levels in exosomes from oligodendroglial cells and B cells supports this theory.27,30 Depleting 
the ESCRT complex has been shown to allow in the successful formation of MVBs.31  
There are two possible fates of the MVB’s: (1) degradation of the MVBs by the 
lysosome, or (2) release of the ILV’s into the extracellular milieu, where they are classified as 




culture with low speed centrifugation. Extracellular vesicles are then isolated from biological 
fluids or cell culture using ultracentrifugation (100,000g). Sucrose density gradients are also 
used in conjunction with ultracentrifugation to further purify exosomes, where they are found 
in the 1.15 to 1.19 g/ml fraction.33 Visual confirmation of exosome size and morphology is 
usually carried out using transmission electron microscopy (TEM) or cryo-electron 
microscopy (cryo-EM).34  
 
Figure 1.2. Cartoon depiction of the formation of exosomes. Adapted from reference 34. 
Exosomes carry a cargo that includes proteins, lipids, miRNA and mRNA.34  Protein 
characterization in exosomes was initially carried out using immunoblotting, immuno-gold 
labeling and antibody-coupled to flow cytometry. 35 However, with the development and 
advent of mass spectrometry based proteomics, over 4000 exosomal proteins have been 




cytoskeletal, endosomal, and cytosolic proteins. They also carry proteins involved in vesicle 
transport.34,35 Tetraspanins, a family of plasma membrane proteins composed of four 
transmembrane domains, are reported to be highly enriched in exosomes. These include 
CD63, CD81, CD82, and CD9, which have been used as exosomal markers. It is important to 
note that no specific marker has been identified for exosomes, and that the protein cargo of 
exosomes is dependent on the cell source and environmental factors.37 Exosomes also carry 
heat shock proteins (Hsc70, Hsc90), cytoskeletal proteins (actin, tubulin, keratin), ESCRT 
complex proteins (Alix, TSG101) and major histocompatibility complex (MHC) I and II 
molecules.36 The protein contents of exosomes shed from MDSC have been reported by 
Burke et al. and include some expected exosomal proteins such as ESCRT complex proteins 
and heat shock proteins.7 Post-translational modifications of proteins in the exosomes have 
been studied too, to gain a deeper understanding of possible structural and functional role of 
these proteins in exosomes. I-Hsuan et al. proposed protein phosphorylation in cancer 
exosomes as breast cancer biomarkers.38 Ubiquitination of proteins in exosomes has 
demonstrated possible involvement of the ubiquitin-sensitive ESCRT complex in exosome 
cargo sorting and biogenesis.39  
Exosomes are players in facilitating communication in the tumor microenvironment. 
They can interact with recipient cells in several ways that include direct ligand-receptor 
interactions, and phagocytosis by the recipient cell. Target cell specificity has been shown to 
be dependent on integrins carried on the surface of the exosome. Studies conducted by Lyden 
et al. and Langano et al. have shown that metastatic niche creation is made possible by 
exosomes and is directed by specific integrins carried by the exosome.40,41 The case for 
communication via ligand-receptor interactions is supported by the fact that exosomes carry a 
host of proteins involved with adhesion on their surface. Buschow et al, have demonstrated 




molecules.42 Felicetti et al. have provided visual evidence of exosomes being taken up by 
recipient cells (Figure 1.3).43 Investigating the surface proteins of exosomes can lead to a 





Figure 1.3. Visualization of exosomes fused with Me1007 cell line using confocal        
microscopy.  Fluorescent BODIPY® FL C16 was incorporated into lipids of the exosome 
membranes. Me1007 recipient cells’ cytoskeleton was stained with phalloidin (Alexa Fluor 
647-red) and nuclei counterstained with Hoechst. (Adapted from reference 40). 
MDSC derived exosomes have been the focus of several studies in this laboratory for 
the last 5 years. Burke et al. first characterized the protein cargoes of exosomes in 
environments of high (4T1/IL-1) and conventional (4T1) inflammation derived from murine 
MDSC.7 The first step in characterizing MDSC derived exosomes was to ensure we had 
purified MDSC from the mice. After three weeks of inoculation with 4T1 or 4T1 and IL-β, 
the leukocytes in the blood of the mice is >90% MDSC. Confirmation is carried out using 
immunofluorescence and flow cytometry of MDSC markers Gr1 and CD11b.7 The purified 
MDSC were maintained in serum free medium overnight to collect exosomes and ensure we 
are only purifying exosomes from MDSC. The exosomes were purified using low speed 
centrifugation to remove cells, ultracentrifugation to pellet exosomes, and sucrose density 
fractionation was use to purify the exosomes. Transmission electron microscopy was used to 
confirm size (50nm diameter) and morphology (circular) of the exosomes. Protein analysis 





S100A8 and S100A9, which are contribute to the immunosuppressive activity of the parental 
MDSC. Finally, migration assays determined that MDSC derived exosomes are chemotactic 
for parental MDSC.7 Therefore, the exosomes purified are also functionally similar to the 
parental cells. Four hundred and twelve proteins were identified in MDSC-derived exosomes 
using bottom-up proteomics. Spectral counting showed an increase in abundance for proteins 
involved in immune responses and membrane budding in animals with heightened 
inflammation conditions. Exosomes from both conditions carry pro-inflammatory mediators 
S100A8 and S100A9, which were reported to provide chemotactic activity for MDSC and 
also to polarize macrophages to a tumor-promoting phenotype.7 Further studies by Burke et 
al. also identified ubiquitinated proteins in the cargoes of inflammatory MDSC-derived 
exosomes. The ubiquitinated protein cohort included several proteins involved in endosomal 
transport and the pro-inflammatory HMGB1.44 Top-down proteomics has also been applied to 
the cargos of MDSC-derived exosomes. Twenty proteins from inflammatory MDSC 
exosomes and fourteen proteins from conventional MDSC exosomes with several 
proteoforms have been identified, including 25 proteoforms of S100A8 and 5 proteoforms of 
S100A9.20 These and other studies provide further evidence that exosomes do not just carry 
junk or degraded pieces of proteins out of cells, and that the possible biological functions of 
exosomes need to be investigated further. 
 
1.4. Ubiquitination 
Ubiquitin (Ub) is a protein found in all eukaryotic cells. It is made up of 76 amino 
acids and acts as a signal by covalently attaching to other proteins. Ubiquitin-like proteins 
(UbL) are a family of proteins, which include Rub1 and small ubiquitin-related modifier 
(SUMO).45 These proteins are similar to Ubiquitin in their amino acid sequences, and this 




structures of these proteins are almost superimposable to the structure of Ub, and key residues 
are maintained between proteins. However, functionally, Ub, Rub1 and SUMO are different. 
Ub is implicated in protein degradation, sorting, trafficking and regulatory functions. In 
contrast, the Rub1 protein is involved primarily with regulatory functions and the SUMO 
proteins regulate cellular processes such as DNA repair and transcription.46,47 While bacteria 
do not contain Ub, they have UbL’s thiaminS (ThiS) and the molybdopterin synthase surfur 
carrier subunit protein (MoaD). These prokaryotic proteins have mechanisms of activation 
similar to Ub and UbL proteins.45  
Ubiquitin attaches to proteins or to itself as a post-translational modification (PTM) 
called ubiquitination. Ub can form an isopeptide bond between the carboxyl terminal glycine 
(G76) and a lysine (K) residue of the substrate protein, or to the initital methionine if the 
substrate protein is another Ub. A protein could have a single Ub attached 
(monoubiquitination), or Ub attached at several sites (multiubiquitination). Ubiquitin can 
form complex internally linked chains since there are eight possible sites of attachment 
(seven lysines and one methionine) (Figure 1.4). These chains can also be anchored onto 
other proteins. In addition, polyUb can consist of chains composed of the same linkage site 
(linear chains) or those with different linkage types (branched chains). It has been ascertained 
that different linkages of anchored and unanchored Ub chains are responsible for a multitude 
of linkage specific cellular functions. For example, K48 anchored chains are responsible for 
proteolytic degradation, K27 anchored chains for host immune response and K6 unanchored 








             
Figure 1.4. The amino acid sequence of Ubiquitin. The amino acid residues which are 
potential sites for ubiquitin isopeptide bond formation are highlighted in green. These include 
the seven lysine residues and the initial methionine.  
 
Several strategies have been developed to identify and characterize ubiquitin chains. 
Anti-Ub antibodies have been produced to isolate and characterize different forms of 
ubiquitin. Some of these antibodies have been produced against a specific linkage of 
ubiquitin, and some are produced for unanchored Ub or polyUb.48 Immunoprecipitation and/ 
or western blotting can be used to isolate Ub tagged proteins or unanchored Ub chains from 
biological samples. However, antibodies are limited in their ability to characterize mixed 
linkages of Ub chains, and ascertain the number of Ub moieties in the chain. Finally, 
antibodies have also not been produced for every linkage type possible in ubiquitination, thus 
some linkages will not be possible to characterize. Another Ub isolation method has been the 
development of tandem ubiquitin binding entities (TUBES).  TUBES are based on ubiquitin 
associated domains (UBA) found on proteins which bind to Ub.49 Four of these UBA’s are 
attached in tandem with a linker (Figure 1.5). It has been shown that each of these UBA’s can 
bind to an Ub molecule and also that it does not bind to other UBL’s like Nedd8 and 
SUMO.50 Commercially available TUBES that bind to polyUb are available. These are not 
able to distinguish between most of the Ub linkages types, and are available with either equal 
affinities toward K48 and K63, or just K63. Deubiquitinases (DUBs) are enzymes, which 
cleave off Ub with linkage specificity. A strategy called UbiCRest (Ubiquitin chain 
restriction) has been developed which uses DUBs to cleave Ub chains with linkage specificity 
and thus determine the linkages of ubiquitinated proteins. The UbiCRest method has been 




has not been tested on longer Ub chains and is so far limited to analyzing Ub dimers. This 
analysis is also limited because DUBs specific for every possible Ub linkage type have not 
been discovered.  Finally, mass spectrometry tools have been developed for the detection and 
evaluation of Ub linkage and topology, which address the limitations in the antibodies, DUBs 
and TUBES protocols that have been developed.53,54  
 
 
Figure 1.5. A cartoon representation of the design of TUBES.  
              
 
1.4.1. Bottom up Proteomics 
Enzymes are known for their residue specificity in proteolysis. This feature of the 
enzymes is exploited as a tool to generate peptides for mass spectrometry analysis. One of the 
most commonly used and commercially available enzymes is trypsin. Trypsin cleaves peptide 
bonds at lysine (K) and arginine (R) residues. Tryptic peptides can be introduced into a mass 
spectrometer after separation by liquid chromatography, to provide a bottom-up proteomics 
approach. The term bottom-up is refers to a strategy that identifies peptides by mass 
spectrometry. The peptide precursor and fragment m/z values detected in the mass 
spectrometer are compared to predicted MS/MS spectral libraries. These spectral libraries are 
generated by an in silico digestion of protein sequences from a database (the user defines the 
proteolysis technique used), which results in all possible peptides produced and their 
predicted MS/MS fragment ion series.55 Tryptic peptides and bottom-up proteomics have 
been used by researchers to study the ubiquitiome. Trypsin cleavage leaves a diglycine (-GG) 




(Figure 1.6).56 The sequencing of peptides by tandem mass spectrometry can identify the 
addition of mass caused by the site of the addition of the –GG tag on the peptide (114.043 
Da). In this way, the location of ubiquitination on the substrate protein can be identified. 
Linkage sites of unanchored ubiquitin can be determined using tryptic cleavage, as the mass 
addition of the –GG tag will be located on the linked lysine residue. This method is however, 
limited in determining the length and topology of the Ub chain attached to the substrate  






Figure 1.6. Cartoon representation of a ubiquitinated protein undergoing cleavage by trypsin. 
The arginine “R” residue on the Ub gets cleaved and leaves a –GG on the peptide from the 




Bottom-up proteomics has disadvantages when it comes to PTM analysis, as one can 































made based on a few peptides, one can lose PTM information. Also, proteins can be found 
with various forms of PTM’s; a bottom-up analysis misses the information of the various 
possible proteoforms present for each protein identified. 
               1.4.2. Top-down Proteomics 
With the evolution of high-resolution mass spectrometers, an alternative approach to 
proteomics has been made possible. Top-down proteomics is an approach in which proteins 
can be analyzed without digestion by an enzyme. In this approach, a protein can be identified 
and studied with all PTMs present. Top-down analysis allows the user to identify proteoforms 
and isoforms of the protein/ proteins of interest.  Unanchored ubiquitin chains of dimers, 
trimer and tetramers, including their topological isomers have been distinguished and studied 
using top-down mass spectrometry.53,54 The studies take advantage of the high resolution 
Fusion Lumos instrument, and ETD (electron transfer dissociation) fragmentation in 
conjunction with supplemental CID (collisional induced dissociation) or HCD (higher-energy 
collisional dissociation) fragmentation capability available. The study is made possible 
because the different linkages of Ub produce fragments with unique masses, which are 
specific for the selected linkage. It is now possible to differentiate polyUb topology and 
linkage length. The next challenge we face is to isolate endogenous ubiquitinated proteins 
from a biological sample and apply the methods established to read the ubiquitin code 





1.5.  Protein Analysis by Mass Spectrometry  
1.5.1. Orbitrap LTQ-XL Mass Spectrometer  
The orbitrap mass analyzer was first developed in the 1990’s. This mass analyzer was 
developed as a way to optimize the Fourier transform ion cyclotron resonance mass 
spectrometry device's (FTICR's) ability to discern ions with a small difference in mass-to-
charge (m/z) values from biological samples. The advantage of this mass analyzer is that 
there is no need for a magnetic field because ion trapping occurs with the use of electrostatic 
fields.57 The LTQ orbitrap-XL was one of the first commercially available orbitrap 
instruments provided by ThermoFisher Scientific. This is a hybrid instrument (Figure 1.7), 
which combines a linear ion trap mass analyzer with an orbitrap mass analyzer, this allowed 
for high resolution analysis with the speed and sensitivity required for liquid chromatography 
(LC) time scale analysis of complex mixtures. The resolving power of this instrument is a 
maximum of 140,000 at 200m/z, which enables studies of small proteins and large peptides.58 
Precursor ions are first accumulated in the C-trap, and then sent to the orbitrap for mass 
analysis. The C-trap was added to interface the continuously operating electrospray source 
with the orbitrap, which does not operate in a continuous fashion. Once the ions are in the 
orbitrap, the mass/charge ratio is measured by recording the frequency of the ions’ 
oscillations inside the trap. Precursor ions are selected for fragmentation either by collision- 
induced dissociation (CID), electron transfer dissociation (ETD) or higher-energy collision 
dissociation (HCD). Fragmentation using CID and ETD occur in the linear ion trap and 
fragmentation by HCD occurs in the multipole region (HCD collision cell) of the mass 
spectrometer (Figure 1.7). For bottom-up analysis of peptides, the most common method of 
analysis by the orbitrap LTQ-XL is to acquire a high resolution full MS scan using the 
orbitrap, and then a data-dependent scan using  tandem mass spectrometry (MS/MS) scan in 




             
              
 Figure 1.7. Overview of the orbitrap LTQ-XL. (http://planetorbitrap.com). 
 
1.5.2. Orbitrap Fusion Lumos Mass Spectrometer  
The latest innovation in orbitrap mass analyzers is the orbitrap Fusion Lumos tribrid 
by ThermoFisher Scientific. This instrument has the newer high-field (HF) orbitrap, which 
provides a higher resolving power (240,000 at 200m/z) without compromising sensitivity. 
The instrument is able to achieve a lower vacuum with a more efficient pumping system, 
which allows for more efficient transfer of ions to the orbitrap for mass analysis. Precursor 
isolation was also improved upon by allowing selection at the quadropole located at the front 
end of the system (Figure 1.6). Fragmentation using CID and ETD is improved upon when 
compared to the LTQ-XL by providing a high-pressure cell in the linear ion trap, which 
increases the efficiency of fragmentation. In the LTQ-XL, the ETD source was at the back of 
the instrument (Figure 1.5). It has now been moved to the front of the instrument (Figure 1.6). 
The ETD reagent fluoranthene anion is generated along with cation and neutral products. As 
it passes through the advanced active beam guide, the anion is separated from the other 
species, which ensures better ETD fragmentation.   
For a bottom-up, discovery based experiment one advantage of using the orbitrap 
Fusion Lumos is that the full scan in the orbitrap can occur in parallel with the MS/MS scan 




increase in the number of peptides identified. Finally, the instrument provides two different 
modes for precursor selection for the MS/MS scan. Previously selection of precursor was 
limited to the Top N mode, in which the user defines the maximum number of precursors that 
can be targeted per cycle. The orbitrap fusion lumos allows for an extra mode called Top 
Speed, which allows the user to define a fixed cycle time for MS/MS scans. This allows for 
the system to perform a maximum number of MS/MS scans in the cycle time defined by the 
user.  
 
















Chapter 2: Identification of surface glycoproteins on MDSC 
derived exosomes and parental cells.  
 
This chapter has been published as a peer reviewed journal article in the Journal of 
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2.1. Introduction  
Proteins on cell surfaces are mediators of cell functions, serving as receptors, 
transporters, and adhesives. They transport nutrition and waste, respond to stimuli from the 
environment, and protect the integrity of the cell. They can also serve as ligands for receptors 
on other cells and deliver signals to surrounding cells in their locale. In the context of the 
tumor microenvironment, CD47 and other surface proteins are considered drug target 
candidates,59,60 as well as biomarkers for distinguishing cells of interest.61,62 Exosomes, 
nanoscale vesicles released by almost all types of cells, have been shown to carry cargos that 
include proteins, lipids, and RNAs and to differ according to the type of parental cells. 
Exosomes are bounded by a phospholipid bilayer that contains tetraspanins and other 
proteins. Tetraspanins CD63, CD81, CD82, and CD9 have been proposed as markers of 
exosomes.37,63,64 Electron micrographs of immunolabeled CD63 clearly show the protein on 
the surface of blood-derived exosomes.65Several other studies also report visualization of 
selected proteins on the surfaces of exosomes.63,66,67 Recent work has highlighted the role that 
integrins on the surface of exosomes play in uptake by recipient cells leading to premetastatic 
niche formation and cancer cell migration.40,41 Here we report an unbiased study of 
glycoproteins on the surface of exosomes released by myeloid-derived suppressor cells 
(MDSCs). Our broad objectives are to identify therapeutic targets for reducing MDSC 
suppressive functions and to gain insight into cell-to-cell communication within the tumor 
microenvironment that promotes tumor progression 
MDSC are immature myeloid cells.  They accumulate in the blood and tumor 
microenvironment of virtually all cancer patients and tumor-bearing mice.  They are an 
acknowledged obstacle to innate anti-tumor immunity and to cancer immunotherapies.68 
MDSC are multifunctional cells that use a variety of suppressive mechanisms to inactivate 




production of reactive oxygen and nitrogen species and by sequestering or degrading amino 
acids that are essential for T cell function; (ii) polarize immunity and macrophages towards a 
type 2 phenotype that supports tumor growth; (iii) prevent naïve T cells from entering lymph 
nodes and becoming activated by down-regulating T cell expression of L-selectin; (iv) inhibit 
the cytotoxic activity of natural killer cells; (v) promote neo-vascularization through their 
production of vascular endothelial growth factor (VEGF); and (vi) promote metastasis 
through their production of matrix metalloproteases.12 
The inflammatory milieu present in most solid tumors exacerbates both the quantity 
and potency of MDSC and induces their differentiation and accumulation from hematopoietic 
progenitor cells.15,21,69 MDSC mediate most of their immune suppressive and tumor-
promoting functions within the tumor microenvironment (TME).  Therefore, MDSC function 
requires that the cells migrate from the bone marrow where they are generated, into solid 
tumors.12 Cell-to-cell interactions, such as those between MDSC and their target cells, are 
frequently initiated by contact between plasma membrane receptors and their soluble or 
membrane-bound ligands. MDSC and other cells in the tumor microenvironment release 
exosomes, which also facilitate communication between cells and promote tumor growth and 
metastasis.7,70,71 Glycoproteins, such as the Receptor for Advanced Glycation Endproducts 
(RAGE), facilitate the activation of MDSC.72 Our previous studies using proteomic 
approaches demonstrated that exosomes released by MDSC contain one of the ligands for 
RAGE,72 and that these proteins are chemotactic for parental MDSC and also polarize 
macrophages towards a tumor-promoting M2 phenotype.7 Based on these findings, we 
hypothesized that proteomic approaches may be useful for identifying additional MDSC 





A number of methods have been developed to take advantage of the unique 
accessibility of molecules at the surfaces of intact cells. These include lectin affinity 
columns,73alkylation of accessible lysine residues with linked biotin,74,75  nanoparticle 
pellicles76,77 and alkylation of oxidized glycans with linked biotin or hydrazide.78–81 We have 
adopted the latter strategy for this study of surface glycoproteins on MDSC-derived 
exosomes and their parental cells. In particular, the milder oxy-amino alkylation method of 
Weekes et al82 was followed because its compatibility with physiological pH minimizes the 
potential for lysing the exosomes.  
We hypothesize that multiple glycoproteins reside on the surface of our exosomes, 
where they play critical roles in exosome-cell interactions.  Here we report the first successful 
adaptation of cell surface methodology to examine the surface of exosomes released by 
tumor-induced mouse MDSC.  The diameters of these exosomes average around 30 nm, on 
the small end of the range reported for exosomes.69 With a high radius of curvature and a 
small surface area, these vesicles provide an appropriate challenge for surface chemistry. We 
have characterized 21 glycoproteins, and show that these meet several criteria for a surface 
origin. We have carried out a parallel identification of ninety-three glycoproteins on the 
surface of parental MDSC, and discuss similarities in composition that are consistent with the 
similar functions reported previously for the exosomes and their parent cells. Because MDSC 
chemotaxis and migration are critical for MDSC function, we have focused our biological 
studies on CD47, an N-glycosylated integral membrane protein identified by our proteomic 
studies.  We report here that CD47, known for its ability to protect cancer cells from 






Section 2.2 Experimental Methods 
2.2.1. Myeloid-Derived Suppressor Cells and Exosome harvesting.  
Female BALB/c mice, 6-10 weeks of age (bred in the University of Maryland 
Baltimore County animal facility from breeding pairs obtained from The Jackson Laboratory, 
Bar Harbor, ME), were injected in the mammary fat pad with 1x105 mammary carcinoma 
4T1 cells transfected with the IL-1β gene (4T1/IL-1β) cells. Mice were bled from the 
submandibular vein when tumors were 9-11mm in diameter. MDSC were harvested from the 
blood, labeled with fluorescently-coupled antibodies to MDSC markers, and assessed by flow 
cytometry (Beckman/Coulter Cyan ADP) for purity, as reported earlier.7,17 Cell populations 
that were >90% pure Gr1+CD11b+ cells were used in these studies.  Approximately 108 
MDSC were obtained from 2-3 mice. 
Following isolation from mice, MDSC were either frozen in 15% DMSO and stored 
at -80°C (for studies with intact MDSC) or maintained in serum-free HL-1 media overnight at 
37°C (for collection of exosomes), as previously described.7 After 16 hrs each supernatant 
containing exosomes was centrifuged at 805xg and 2090xg to remove residual cells and then 
ultracentrifuged at 100,000xg to pellet the exosomes. In a previous study the pellet was 
shown to comprise homogeneous exosomes with diameters 25-30 nm and density of 1.2-1.3 
g/ml.7 Pellets containing the exosomes were resuspended in PBS and absorbances were 
measured at 260 and 280 nm. Protein concentration was assessed by Bradford Quick Start 
assay (Biorad, Hercules, CA). Exosomes were never frozen and were used fresh within a 







2.2.2. MDSC and Exosome cell surface chemistry 
Approximately 108 MDSC cells were washed with 50 mM PBS (CaCl2, MgCl2, pH 
7.4), and then incubated in 1mM sodium periodate in 50 mM PBS (CaCl2, MgCl2, pH 7.4, 5% 
FBS) for twenty min at 4°C in the dark to oxidize surface glycans. Oxidized glycans were 
biotinylated in 100 µM aminooxy-biotin and 10 mM aniline (in PBS with CaCl2, MgCl2, 5% 
FBS, pH6.7) for 1 hr at 4 °C, washed two times with PBS (CaCl2, MgCl2, pH 7.4)                   
(centrifuged 5 minutes at 900xg), and then re-suspended in lysis buffer (150 mM NaCl, 5 mM 
IAA, 10 mM Tris-HCl, triton X-100, and protease inhibitor cocktail) and incubated overnight 
at 4 °C. The following day, mechanical lysis was carried out. The nuclear material and debris 
was removed by two 40 min centrifugations at 2,800xg, followed by two 40 min 
centrifugations at 16,000xg. During the final centrifugation streptavidin beads were prepared 
in snap cap spin columns (Pierce, Rockford, IL) via two washes (one min at 1,000xg) in lysis 
buffer. The cell lysate was incubated on-column for 2 hr at 4 °C. The beads were washed 
with lysis buffer and PBS (pH 7.4 0.5 % SDS). Proteins were reduced on column with 100 
mM DTT in PBS (pH 7.4 0.5 % SDS) for 20 min at room temperature. The beads were then 
washed with urea containing (UC) buffer (6 M urea, 100mM Tris-HCl) and alkylated with 
50mM iodoacetamide (IAA) in UC buffer for 20 min at room temperature. The biotinylated 
glycoproteins were digested on-column using 5µg of trypsin in 50 mM ammonium 
bicarbonate at room temperature, overnight. The tryptic peptides, released from the beads and 
present in the supernatant were collected by centrifugation, and a C18 column cleanup was 
performed. The snap cap columns were washed with PBS, followed by milliQ water, and G7 
buffer (50 mM sodium phosphate). The N-glycopeptides (still attached to the beads) were 




peptides were eluted from the beads and are present in the supernatant, which was then 
collected by centrifugation. 
Preparation of surface proteins from exosomes was performed with starting material 
of exosomes collected from 1x109 MDSC. The exosomes were incubated in 1 mM sodium 
periodate in 50 mM PBS (CaCl2, MgCl2, pH 7.4) for twenty minutes at 4 °C in the dark and 
then centrifuged at 100,000xg for 70 minutes. Exosome pellet was washed with PBS (CaCl2, 
MgCl2, pH 7.4, 2% BSA), and another 100,000xg spin was performed. The supernatant was 
removed and the pellet was resuspended in a solution of 100µM amino-oxy-biotin and 10 
mM aniline (in PBS, w/CaCl2, MgCl2 2% BSA, pH 6.7) and incubated for 1 hour at 4°C. 
Intact exosomes were then washed with PBS (CaCl2, MgCl2, pH 7.4, 2% BSA) (70min, 
100,000xg), and then re-suspended in 100 µl PBS (pH 7.4) and incubated overnight at 4°C. 
The following day exosomes were lysed in 8 M urea. Fifty milimolar NH4HCO3 was added to 
each sample to dilute the final urea concentration to 0.8 M. Streptavidin beads were prepared 
in snap cap spin columns. The exosome lysate was incubated on-column for 2 hr at 4°C. The 
beads were washed with ammonium bicarbonate and PBS (pH 7.4 0.5% SDS). Proteins were 
reduced on column with 100mM DTT in PBS (pH 7.4 0.5% SDS) for 20 minutes at room 
temperature. The beads were then washed with UC buffer and alkylated with 50mM IAA in 
UC buffer for 20 min at room temperature. The biotinylated glycoproteins were digested on-
column using 0.75 µg of trypsin in 50 mM ammonium bicarbonate. The tryptic peptides were 
collected by centrifugation, and a C18 column cleanup was performed. The snap cap columns 
were washed twice with PBS, followed by two washes with milliQ water, and two more 
washes with G7 buffer. The N-glycopeptides (still attached to the beads) were released via 











Figure 2.1. Cartoon representation of the surface glycoprotein enrichment strategy used. 
2.2.3. HPLC-MS/MS Analysis.  
             Tryptic peptides and glycopeptides from both MDSC and exosome samples were 
fractionated on a C18 analytical column (Grace Vydac, Deerfield, IL) in line with an LTQ-
orbitrap XL (Thermo Scientific, San Jose, CA) with a combined linear gradient of 0- 40% 
solvent B (97.5% CAN (acetonitrile), 2.5% H2O, and 0.1% formic acid) over 140 min and 40 
to 85% solvent B over an additional 25 min. The flow rate was 500nL/min. Precursor ion 
scans were recorded at a resolution of 30,000 at 400 m/z in the orbitrap. In each cycle the 
nine most highly abundant precursor ions were isolated for fragmentation via collisional 
induced dissociation (CID) in the ion trap.  Fragment ions were analyzed in the ion trap. 
Samples from one biological replicate each of the parental cells were also analyzed on an 
orbitrap Fusion. In this case peptides from parental cells were fractionated on a C18 Easy 




5-32% acetonitrile/ 0.1% formic acid through 120 min at a flow rate of 500 nL/min. Spectra 
were acquired using a resolution of 120,000 (at 200 m/z) for full scans, followed by HCD 
fragmentation and detection of the fragment ions in the ion trap in the Top N mode.  
In total three biological replicates were analyzed for MDSC and four for the MDSC 
exosomes. Between three and six injections were examined for each biological replicate.  
2.2.4. Bioinformatics 
Spectra were converted to peak lists and reformatted as mzXML using msconvert 
from the ProteoWizard project83 and uploaded to the PepArML peptide identification meta-
search engine84 for searching using MS-GF+.85 Spectra were searched against the UniProtKB 
reviewed mouse reference proteome (August 2015). Precursor ion tolerance of 0.05 Da was 
required for either the monoisotopic or first 13C peak of the precursor isotope cluster, and 
tolerance of 0.5 Da was used for fragment ion matching. A fixed carbamidomethylation Cys 
modification was specified throughout. Peptides were required to match the trypsin 
proteolytic digest motif at both the N- and C- terminus. Up to two missed trypsin cleavages 
were permitted. Spectral FDR (false discovery rate) was estimated using a reversed protein 
sequence database. 
Peptides in the fraction resulting from PNGaseF deglycosylation and release of 
glycan-bound tryptic glycopeptides were searched using variable deamidation of Asn 
residues in the N-X-S/T glycosylation sequence motif and only those peptides with a 
deamidation mass-shift (+0.98 Da), characteristic of N-glycan cleavage, were retained. 
Peptides in the fraction resulting from tryptic digestion of bound glycoproteins were searched 
separately, without this variable modification, and the resulting peptide identifications 
combined with the PNGaseF fraction deglycosylated glycopeptides. Protein parsimony 




filtering at 5% spectral FDR, to infer glycoproteins. In addition, at least one deglycosylated 
glycopeptide identification from the PNGaseF fractions was required for each inferred 
protein. Proteins inferred on the basis of a single deglycosylated glycopeptide were held to a 
higher standard, with the single deglycosylated glycopeptide identified required to satisfy 
spectral FDR at most 1% and to have a unique alignment to UniProt reviewed mouse 
reference sequences. Protein FDR for the unified parsimony analysis was 2.05%, estimated 
by tracking decoy peptides and proteins throughout the protein inference procedure.  
Nine of the twenty-one exosome proteins were identified based on the identification 
of a single deglycosylated glycopeptide. Six of these are matched to more than one spectrum.  
In the parental MDSC cell surface analysis 18 glycoproteins out of 93 were identified based 
on a single PNGaseF fraction deglycosylated glycopeptide. Stringent one-peptide 
identifications for the surface proteins have been considered sufficient by other laboratories 
exploring surface glycoproteins.86 
The NetNglyc server was used to predict N-Glycosylation sites on peptides identified 
from the PNGaseF fraction.87 Uniprot and Protter were used to make predictions on topology 
domains of the glycopeptides.88  
2.2.5. Bioassay for MDSC Chemotaxis 
             MDSC chemotaxis with exosomes was assessed as previously described with the 
following modifications.7 Intact MDSC from 4T1-tumor-bearing mice (1 x 106 of >90% 
Gr1+CD11b+ cells) were placed in the upper chamber of transwells containing an 8µm filter 
and MDSC-derived exosomes were placed in the lower chamber.  In some experiments 
MDSC-derived exosomes were pre-mixed at 4°C for 1 hr. with 5 µg/ml antibodies to mouse 
CD47 (clone miap301, Rat IgG2a, catalog #127501, BioLegend), mouse thrombospondin-1 




(SIRPα; CD172a, clone P84, catalog #144002, BioLegend), or the irrelevant isotype matched 
control antibodies rat IgG2a (clone RTK2758, #400515, BioLegend), mouse IgG1 (clone 
P.3.6.2.8.15, #16-4714-83, EBioscience), or rat IgG1 (clone BRG1, #16-4301-85, 
EBioscience), respectively.  Pre-incubated exosomes or medium containing no exosomes was 
then added to the lower chamber of the transwells and the transwells incubated at 37°C, 5% 
CO2.  At the end of 4 hrs, cells migrating to the lower chamber were counted by 
hemocytometer.  In some experiments, parental MDSC were pre-treated at 5µg/ml with the 
CD47, TSP-1, SIRPα, or corresponding irrelevant isotype matched antibodies for one hour at 
room temperature, and unbound antibody removed by washing with PBS.  Samples were run 
in triplicate and each sample was counted six times.  Values are the average ± SD of triplicate 
samples per experimental condition. % migration = {experimental-control medium)/ 
(exosomes-control medium)} x 100%. Statistical analysis was by Student’s t- test. 
 
2.3. Results and Discussion 
Twenty-one surface N-glycoproteins have been identified on the exosome samples 
and are listed in Table 2.1. Twenty-one protein identifications were based on twenty-five N-
glycopeptide identifications (Appendix 2.1) on twenty-five sites. All glycopeptides contain a 
motif for N-glycosylation in which an asparagine has been modified (by PNGaseF cleavage) 
to aspartic acid. Sixteen of the glycosylation sites have been previously identified in other 












Table 2.1. N-Glycoproteins identified on the surface of exosomes released by MSDC.           
Asparagine residues in the motif N-X-S/T, which were deamidated upon release by   






DQCIVDDITYNVNDTFHK P11276 Fibronectin 
LDAPTNLQFVNETDR P11276 Fibronectin 
TEAADLCQAFNSTLPTMDQ
MK P15379 CD44 
INLTTNVVDVNRPLPLAAY
NNR Q3UZZ4 Olfactomedin-4 
DAMVGNYTCEVTELSR Q61735 Leukocyte surface antigen CD47 
DSSGVINVMLNGSEPK Q64277 ADP-ribosyl cyclase/ CD157 
AVNQTGALYQCDYSTSR P05555 Integrin alpha-M/ CD11b 
LNYTLVGEPLR P05555 Integrin alpha-M/ CD11b 
YLNFTASEMTSK P05555 Integrin alpha-M/ CD11b 
ISENGSSVAGILSSPNMEK Q9Z0M6 CD97 
VVIRPFYLTNSTDMV Q07797 Galectin-3-binding protein 
VVNVSELYGTPCTK P55772 
Ectonucleoside triphosphate 
diphosphohydrolase 1/ CD39 
DCIQSGPGCSWCQKLNFTG
PGEPDSLR P11835 Integrin beta-2/ CD18 
AFMNSSFTIDPK O88792 Junctional adhesion molecule A/ CD321 
ALMPFDSLHDDPCLLTNR(
S) P11247 Myeloperoxidase 
KVSCPIMPCSNATVPDGEC
CPR P35441 Thrombospondin-1 
VVNSTTGPGEHLR P35441 Thrombospondin-1 
GFCEADNSTVSENNPEDWP
VNTEGCMEK P40237 CD82 
FLEQQNQVLQTKWELLQQ
VNTSTR Q6IFZ6 Keratin, type II cytoskeletal 1b 
YKGTAGNALMDGASQLVG
ENR(T) Q8K0E8 Fibrinogen beta chain 
GTAGNALMDGASQLVGEN
R(T) Q8K0E8 Fibrinogen beta chain 
VQGCMSQPGCNLLNGTQTI
GPVDVSER Q8R2S8 CD177 
AELSNVSDTVWNIR Q9D8U6 Mast cell-expressed membrane protein 1 
IVDVNLTSEGK Q9ET30 Transmembrane 9 superfamily member 3 
ALNASQEETGAVFLCPWK Q9QUM0 Integrin alpha-IIb/ CD41 




From the surface of the parental MDSC, 188 N-linked glycopeptides were 
characterized, supporting the identification of 93 glycoproteins (Appendix 2.2). On sixteen of 
these glycopeptides we identified glycosylation at two sites. In all, 204 glycosites are 
identified. One hundred and fifty-two of the 204 observed sites of N-glycosylation have 
already been confirmed by experimental evidence in other studies89 while 52 are 
characterized for the first time here. Twenty-seven of the latter cohorts are not predicted by 
the NetNGlyc database (Appendix 2.3). 
The topological domains of the N-linked glycosites identified from the exosomal 
surface were also evaluated, seeking confirmation of the fidelity of oxidative alkylation on 
the surface of our exosomes (Appendix 2.4). Based on the chemistry, we would expect all the 
glycopeptides observed to originate in solvent accessible regions of the proteins. Relevant 
topologic information is not available for all of the proteins, however the majority of 
glycosites identified on the surface of the exosomes, and also on the parental MDSC surface, 
can be assigned to extracellular regions of their proteins. A few glycosites originate from 
proteins in the extracellular space and some from GPI anchored proteins that do not have 













Figure 2.2. Origins of N-linked glycopeptides identified on the surfaces of parental MDSC 
and exosomal N-glycopeptides. The topology information was created using Uniprot and 
Protter. 
Cluster of differentiation (CD) proteins (named after a protocol used for the 
identification of cell surface molecules) are of particular interest because of their interactive 
functions at the cell surface.  Ten CD proteins were identified on the exosomes, and thirty-
five on MDSC (Fig. 2.3). The CD proteins found on surfaces of both parental cells and 
exosomes include CD11b (also known as Mac-1), which is used as a marker for MDSC 
although it is also expressed on other hematopoietic cells. CD47 was also found on both 
surfaces and is of interest as it is reported to prevent phagocytosis by macrophages and 
thereby protects cancer cells from immune destruction.90 CD82 found on both surfaces is 
























Figure 2.3. CD proteins identified on the surfaces of the MDSC and MDSC derived                                
exosomes.  
 
The similarity or difference between proteins carried by exosomes and their parental 
cells is of considerable interest to researchers studying the role of exosomes in intercellular 
communication.92–94 In the present study, 17 of the 21 exosome glycoproteins were found in 
common on the surface of parental MDSC with N-linked glycopeptide identifications on 
exosomes.  Another three proteins identified on the basis of N-glycopeptides in exosomes are 
supported by tryptic peptides in MDSC (ADP-ribosyl cyclase (CD157), transmembrane 9 
superfamily member 3, and endothelial lipase) (Appendix 2.5). Only junctional adhesion 
molecule A (CD321) was identified on the exosome surface but not detected at all in our 
current examination of parental MDSC samples. Intriguingly, ADP-ribosyl cyclase (CD157) 
is identified in the exosomes by virtue of one deglycosylated glycopeptide and no tryptic 





































deglycosylated glycopeptide, suggesting it is differentially glycosylated in exosomes. The 
overlap between exosome and parental MDSC surface proteins demonstrated here exceeds 
80% (17 of 21 proteins) and suggests that the surface of the exosomes primarily carry 
proteins representative of the surface of the primary cells that released them.  
Exosomes are proposed to transport active biomolecules from sender cells to receiver 
cells, a hypothesis that raises questions about recognition and adhesion (as well as 
transmembrane mechanisms).95–99 We have shown that MDSC exosomes stimulate migration 
of MDSC,7 and we have summarized in Table 2.2  glycoproteins known to be partners in 
receptor/ligand interactions and thus, potentially, in MDSC/exosome couplings. Leukocyte 
surface antigen (CD47) and CD44 on the exosome surface both bind glycoproteins identified 
on the MDSC surface100,101 and CD29 and CD172a on the MDSC surface bind to TSP-1,102 
and fibrinogen,103 respectively, identified on the exosome surface. Most of the cell surface 
molecules listed in Table 2.2.  are also receptors or ligands expressed by other cells in the 
tumor microenvironment.104–108 Our survey appears to support adhesion between exosomes 
and cells, though not yet selective recognition. 
 




integrin alpha-IIb/ CD41 thrombospondin, fibronectin, fibrinogen 
integrin alpha-M/ CD11b haptoglobin, fibrinogen, fibronectin 
integrin beta-2/ CD18 haptoglobin, fibrinogen 




thrombospondin-1 CD29, leukocyte surface antigen (CD47) 
 
                 MDSC-derived exosomes exhibit immunosuppressive functionalities similar to 
that of their parental cells7 and proteins on their surface should similarly be considered as 




study on the surfaces of both MDSC and MDSC-derived exosomes. CD47 is particularly 
interesting because cancer cells express elevated levels of CD47, which sends a “don’t eat 
me” signal when it complexes with CD172a (signal regulatory protein alpha or SIRPα), 
thereby preventing phagocytosis by macrophages.90 CD47 is also known to affect cellular 
aggregation and migration, 109 and it is currently under investigation as a potential therapeutic 
target against cancer.59,60 These characteristics made CD47 an interesting candidate for 
functional assays.  
MDSC mediate their immune suppressive functions within the tumor 
microenvironment.  Since MDSC are generated in the bone marrow and traffic via the 
circulatory system, their entry into solid tumors involves chemo attraction.  Our previous 
studies have demonstrated that tumor-derived inflammatory factors72  and MDSC-derived 
exosomes facilitate this chemoattraction.7 The ability of the MDSC to sense a 
chemoattraction signal is studied using transwell migration assays. Transwell migration 
assays consist of cells being placed on the upper chamber of a transwell with a semi-
permeable membrane. The lower chamber has a solution that contains cells or exosomes, 
which generate the chemoattractant signal. The cells in the upper chamber cannot fall through 
the semi-permeable membrane, but need to change shape in a process that mimics 
extravasation in order to cross over to the lower chamber. This migration of the cells from the 
upper to the lower chamber is a result of the chemoattractant signal released by cells or 
exosomes in the lower chamber.110 In the case of our studies, we expect that secreted proteins 
from cells in the upper chamber will be released, and move to the lower chamber through the 
semipermeable membrane. The secreted proteins will bind to their receptor on the surface of 
either cells or exosomes in the bottom chamber, which will lead to the release of chemotactic 
molecules. The released cytokines serve as a chemoattractant to the cells in the upper 




duration of the assay.  We first confirmed by flow cytometry that parental MDSC express cell 
surface CD47 by staining MDSC with an antibody specific to CD47 or an irrelevant isotype 
matched antibody (Fig. 2.4.A).  As expected from the proteomic analysis, MDSC expressed 
high levels of CD47. To determine if CD47 impacts MDSC migration, we used a transwell 
system in which MDSC were placed in the upper chamber of a transwell containing a 
semipermeable membrane, and MDSC-derived exosomes were placed in the lower chamber. 
Ability of the exosomes to chemoattract parental MDSC was determined by quantifying the 
number of MDSC migrating into the lower chamber. The role of CD47 was determined by 
assessing MDSC migration in the presence of an antibody that sterically blocked CD47.  In 
the absence of exosomes, MDSC did not migrate, confirming that exosomes are chemotactic 
for MDSC.  Preincubation of the exosomes with increasing quantities of anti-CD47 antibody, 
but not an irrelevant control antibody, significantly decreased the number of migrating 
MDSC (Fig. 2.4B). These results indicate that CD47 facilitates exosome-mediated migration 




Figure 2.4. CD47 regulates MDSC chemotaxis and migration in response to MDSC-derived 
exosomes. (A) Parental MDSC express CD47 on their cell surface. Tumor-induced MDSC 
were stained with fluorescent antibody to CD47 or with irrelevant control isotype-matched 
antibody and analyzed by flow cytometry. (B) BALB/c tumor-induced MDSC were placed in 
the upper chamber of a transwell and MDSC-derived exosomes, with or without titered 
quantities of antibody to CD47 or irrelevant control antibody IgG2b were placed in the lower 
chamber. MDSC migrating to the lower chamber were quantified by counting. * indicates 




exosomes with isotype control antibody (p<0.02).  Data are from one of six independent 
experiments with 5µg/ml CD47 antibody. 








Figure. 2.5. CD47 on MDSC-derived exosomes, and not CD47 on intact (parental) MDSC 
regulates MDSC chemotaxis and migration. Chemotaxis assay was performed as in fig. 1 
except (A) exosomes or (B) MDSC in some samples were pre-treated with antibody to CD47 
or an irrelevant isotype matched antibody prior to their placement in the transwells. Data are 
representative of one of six and three independent experiments for (A) and (B), respectively. 
CD47 binds two ligands: the secreted protein thrombospondin-1 (TSP-1) and the 
integral membrane protein SIRPα. Our proteomic analysis identified TSP-1 in both parental 
MDSC and MDSC-derived exosomes, while SIRPα was only detected in the parental MDSC.  
Exosome driven chemotaxis of MDSC could involve either or both of these ligands and either 
the MDSC or the exosomes could express the receptor CD47 or the ligand TSP-1 or SIRPα.  
To determine whether CD47 is used by the MDSC and/or the exosomes, exosomes or MDSC 
were pre-treated with blocking antibodies to CD47 or an irrelevant control isotype matched 
antibody prior to inclusion in the migration assay.  Anti-CD47 antibody pre-treatment of the 
exosomes (Fig 2.5A), but not the MDSC (Fig. 2.5B) prevented migration, while the irrelevant 
antibody had no effect.  These results indicate that the exosomes, and not the MDSC use the 
integral membrane protein CD47 as the receptor. Since the receptor CD47 is functional on the 
exosomes, MDSC chemotaxis could involve MDSC-produced TSP-1 and/or SIRPα.  To 
determine if either of these ligands are involved, and to ascertain if MDSC are the source of 




prior to inclusion in the migration assay.  Pre-treatment of either exosomes or MDSC with 
antibodies to TSP-1 significantly decreased MDSC migration (Fig. 2.6A and 2.6B, 
respectively).  Since antibodies cannot be removed from the exosome solution prior to the 
assay, these anti-TSP-1 antibodies could be neutralizing TSP-1 produced by either the MDSC 
or exosomes. In contrast, pre-treatment of either exosomes or MDSC with blocking 
antibodies to SIRPα only minimally reduced MDSC migration and this trend was not 
statistically significantly different from the effect of the irrelevant antibody controls (Fig. 
2.7A and 2.7B, respectively).  These results demonstrate that TSP-1 is the dominant CD47 




Figure 2.6. Thrombospondin-1, a ligand for CD47, is produced by parental MDSC and 
facilitates MDSC chemotaxis and migration.  Chemotaxis assay was performed as in Fig. 1 
except (A) exosomes or (B) MDSC in some samples were pre-treated with antibody to 
thrombospondin (TSP-1) or an irrelevant isotype matched antibody prior to their placement in 
the transwells. Data are representative of one of three and one of two independent 
































Figure 2.7. SIRPα, a ligand for CD47, is produced by parental MDSC and may contribute to 
MDSC chemotaxis and migration. (A) Chemotaxis assay was performed as in fig. 1 except 
(A) exosomes or (B) MDSC in some samples were pre-treated with antibody to SIRPα, 
antibody to CD47, or an irrelevant isotype matched antibody prior to their placement in the 
transwells.  Data are representative of one of three and three independent experiments for (A) 





We have successfully established a method to identify glycoproteins on the surfaces 
of exosomes, and demonstrated that multiple glycoproteins are present on the surface of 
MDSC-derived exosomes. About 80% of the surface glycoproteins on these exosomes were 
also identified on the surface of parental MDSC, providing further support to the conclusion 
that the protein cargo in exosomes closely resembles that of the parent cells.  Our studies 
identified numerous molecules that have the potential to regulate exosome activity and 
function.  For example, exosomes were observed to contain CD321 (also known as junctional 
adhesion molecule A, encoded by the F11R gene).  In addition to its function in cellular tight 
junctions, CD321 binds to leukocyte function antigen 1 (LFA-1 or CD11a) which we 




derived exosomes might deliver their immune suppressive cargo to T cells by their binding of 
CD321 to T cell LFA-1.   
 
The leukocyte surface antigen CD47 and its ligand TSP-1 were among eight CDs 
found on both cell and exosome surfaces.  CD47 is well known for its ability to protect tumor 
cells from phagocytosis. Our studies demonstrate that CD47 also promotes tumor progression 
by enhancing the trafficking of immune suppressive MDSC and thereby inhibiting anti-tumor 
immunity.  Therefore, in-progress clinical trials testing the therapeutic effect of antibodies to 
CD47 may not only demonstrate direct effects on tumor cells, but may also facilitate the 































Chapter 3: Ubiquitome of MDSC derived exosomes under 
heightened and basal inflammatory conditions. 
This work was jointly authored by Katherine Adams, who performed the sample preparation, 
and the LC-MS/MS analysis, and Sitara Chauhan, who performed the data processing and 
analysis. The data collected by Katherine Adams has been published in her master’s 
thesis,112but has been reanalyzed in this document. 
 
 
Section 3.1 Introduction 
Myeloid derived suppressor cells accumulate in the tumor microenvironment of 
experimental mice and patients, where they are able to suppress innate and adaptive immune 
responses and thus contribute to tumor growth. 13 The accumulation of MDSC in the tumor 
environment is exacerbated by the presence of proinflammatory mediators.7,113 These include 
inflammation-associated molecules vascular endothelial growth factor (VEGF), granulocyte-
macrophage colony-stimulation factor (GM-CSF), prostaglandin E2 (PGE2), interleukin 1-
beta (IL-1β), and calcium-binding proteins S100A8 and A9 (S100A8/A9). Some of these 
molecules are shed by tumor cells (prostaglandin E2), and are found to induce differentiation 
of myeloid cells to form MDSC. IL-1β is another proinflammatory cytokine, which has 
shown to promote tumor growth through the induction of MDSC.72 
Increased levels of MDSC are observed when mice are inoculated with tumor cells 
secreting IL-1β.7 S100A8 and S100A9 are proinflammatory proteins, which have elevated 
levels in diseases associated with increased inflammation. Similar to previously discussed 




Therefore, increases in inflammation, increase the potency of MDSC immune suppressive 
activity by a host of different factors found in the tumor microenvironment.  
The role of inflammation on exosomes shed by the MDSC is therefore worth 
investigating. A previous study has compared the protein cargoes of exosomes shed by 
MDSC from a higher inflammatory environment (INF) to exosomes shed by MDSC from a 
conventional inflammatory environment (CON). This study found that proteins S100A8 and 
S100A9 were found in both INF and CON exosomes but their relative abundances did not 
change in exosomes from higher inflammation. The study found 30 proteins to have 
increased relative abundances in heighted inflammation. Functions of these proteins involved 
membrane budding, GTP/ATP binding and protein sorting.7  
Ubiquitination as a post-translational modification (PTM) is involved in the 
regulation of a multitude of cellular pathways. Many of its functions are based in linkage 
type, for example K-48 linked Ub chains are involved with tagging proteins for degradation. 
K-63 linked Ub on the other hand is functionally responsible for the regulation of 
inflammatory pathways.114 K-63 linked chains bind to, and activate proteins called pattern 
recognition receptors, which in turn lead to the activation of NF-κB pathway.115 The NF-κB 
pathways has been associated in MDSC function as IL-Iβ has been shown to activate MDSC 
through the NF-κB pathway.21 
Extracellular Ub has specifically been shown to affect the functioning of immune 
responses. Ubiquitin has been discovered in extracellular fluid and has been found to be 
responsible for differentiation of hematopoietic and lymphocyte cells. A mutation in 
components of the linear ubiquitin chain assembly complex (LUBAC), which is involved in 
innate immunity response in mice ad humans, causes immune disorders and activation of the 




antigen presenting cells, and thus deregulate normal immune responses. Conjugation of Ub to 
target proteins is carried out by E3 ligases and three specific E3 ligases (casitas B-lineage 
lymphoma proto-oncogene B [Cbl-b], itchy E3 ubiquitin protein ligase [Itch], and gene 
related to anergy in lymphocytes [GRAIL]) are known to have increased expression, which 
then affects T-cell receptor signaling.116  
In exosomes, ubiquitination has been proposed to influence the sorting of proteins in 
several ways. Ubiquitination is involved in the internalization of surface proteins,114 and 
sorting proteins into luminal vesicles,117 which eventually give rise to exosomes. The 
endosomal sorting complexes required for transport (ESCRT) machinery is known to mediate 
the formation of endosomes and is also thought to participate in the invagination of the 
limiting membrane to form ILV’s, which are later released from the cell as exosomes. The 
ESCRT proteins- ESCRT-0, –I and,  -II contain ubiquitin binding domains, which help them 
to bind to Ub, and deliver the Ub proteins into the endosomes.118 Investigators have 
previously proposed that Ub is removed from proteins that are sequestered into ILVs destined 
to be released as exosomes.117,119 However, recent identifications of significant numbers of 
ubiquitinated proteins in the lysates of exosomes from a variety of cell types are cited to 
contradict this mechanism.39 This phenomenon could be explained by the fact that ESCRT-
independent sorting mechanisms have been recently identified in the formation of exosomes 
(Figure 3.1).34,120 A few studies have discovered that exosomes have an enhanced Ub 
conjugation to cellular protiens.39,121 Srinikanth and colleagues found that Ubiquitin in 
exosomes was responsible for causing degradation of CD63 in macrophages, which results in 
suppressing platelet thrombosis. These results point to the fact that studying the role of 
ubiquitination in exosomes and immune responses is of utmost importance and is still not 






Figure 3.1. ESCRT independent and ESCRT dependent pathways regulate the formation of 
exosomes. Adapted from reference 119.  
Polyubiquitination is a large modification; the ubiquitinated proteins are usually 
present at sub-stoichiometric levels compared to their unmodified proteoforms.122–124  This 
can make studying this PTM particularly challenging. However, based on previous studies on 
exosomal ubiquitinated proteins, we hypothesized that the MDSC-derived exosomes will 
contain enhanced ubiquitination of their protein cargo. The present study uses state-of-the-art 
mass spectrometry optimized for bottom-up proteomic analysis to compare the proteomes 
recovered from exosomes shed by MDSC isolated from tumor-bearing mice with high and 





Section 3.2 Experimental Methods 
             3.2.1. Myeloid-Derived Suppressor Cells and Exosome Harvesting.  
              Female BALB/c mice, 6-10 weeks of age (bred in the University of Maryland 
Baltimore Campus [UMBC] animal facility from breeding pairs obtained from The Jackson 
Laboratory, Bar Harbor, ME), were injected in the mammary fat pad with 7,000 4T1 cells 
transfected with the IL-1β gene (4T1/IL-1β) cells. Other mice were injected with 4T1 cells, 
which were not transfected with IL-1β. Mice were bled from the submandibular vein when 
tumors were greater than 8 mm in diameter. MDSC were harvested from the blood, labeled 
with fluorescently-coupled antibodies to MDSC markers, and assessed by flow cytometry 
(Beckman/Coulter Cyan ADP) for purity.7,17 Cell populations that were >90% pure 
Gr1+CD11b+ cells were used in these studies.  Approximately 108 MDSC were obtained from 
2-3 mice.       
                Three biological replicates of exosomes, from each high and low level of 
inflammation were used for this study. Each replicate of exosomes was collected from 1 x 108 
MDSC pooled from 2-3 mice.  Following isolation from mice, MDSC were maintained in 
serum-free HL-1 media overnight at 37°C to collect exosomes.7 After 18 hours, each 
supernatant containing exosomes was centrifuged at 805xg and 2090xg to remove residual 
cells and then ultracentrifuged at 100,000xg to pellet the exosomes. Pellets containing the 
exosomes were resuspended in phosphate buffered saline (PBS) and they were stored at         
-80°C with deubiquitinase (DUB) inhibitors added.  
                3.2.2. Protein Analysis 
                Exosomes were lysed by suspension in 8 M urea in 50 mM ammonium bicarbonate 




protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO).  The solution was centrifuged at 
13,000 xg for 30 min through a 3 kDa molecular weight cut off filter (Millipore, Darmstadt, 
Germany), and the filtrate was discarded.  This process was performed three times before the 
buffer was diluted to 0.8 M urea in 50 mM ammonium bicarbonate.  Protein content was 
measured using the Pierce BCA Assay Kit (Thermo Fisher Scientific, San Jose, CA). 
                A solution containing 25 µg of protein lysate was digested with trypsin. This 
normalized the amount of total protein between the two samples- CON and INF exosomes. 
Samples were reduced with 20 mM dithiothreitol (Sigma Aldrich, St. Louis, MO) for 30 min 
at 56°C and alkylated with 10 mM methyl methanethiosulfonate (Sigma Aldrich, St. Louis, 
MI) for 45 min.  Trypsin (Promega, Madison, WI) was added for a final 1:50 enzyme: protein 
concentration and digestion was performed overnight at 37°C before addition of 0.1% formic 
acid.  Three technical replicates of 1 µg total protein were prepared and analyzed by LC-
MS/MS for each of three biological replicates. 
3.2.3. LC-MS/MS and Bioinformatics Analyses 
A bottom up strategy was used to provide the most inclusive and extensive inventory 
of MDSC exosomes. LC-MS/MS analyses were performed on an Ultimate 3000 nano-HPLC 
system (Dionex, Sunnyvale, CA) in-line with an orbitrap Fusion Lumos Tribrid mass 
spectrometer (Thermo Fisher Scientific, San Jose, CA).  A 2 µL aliquot of tryptic peptides 
was injected onto a C18 column (Dionex, Sunnyvale, CA) and desalted with 10% solvent A 
(97.5% H20, 2.5% ACN, and 0.1% formic acid) for 10 min.  Peptides were fractionated on a 
C18 column (Dionex, Sunnyvale, CA) with a 2 hr linear gradient at a flow rate of 300 nL/min 
increasing from 5 to 55% solvent B (97.5% ACN, 2.5% H2O, and 0.1% formic acid) in 90 
min, followed by an increase from 55 to 90% solvent B in 5 min, and held at 90% solvent B 




200.  The most abundant ions, as many as possible (Top-Speed mode on Fusion Lumos), 
during each 3-second duty cycle were selected for fragmentation by collisional induced 
dissociation (35% collision energy) in the ion trap, and product ion scans were acquired in the 
ion trap.  A dynamic exclusion of one repeat count over 30 seconds was used.  
 Peptide and protein identifications were carried out using PepArML (28) meta-
search engine against the UniProt mouse database (11 2016).  Peptide matches were filtered 
at 1% spectral false discovery rate (FDR), and global protein parsimony required at least 2 
unshared peptides.  This resulted in a protein FDR of < 3.3%.  Fixed modifications listed 
methylthio modification of cysteine, and variable modifications included oxidation of 
methionine, glycinylglycine modification of lysine and N-terminal residue pyrrole 
modifications.  
                Once the exosomal proteins were identified, additional GG-tagged peptides with at 
most 10 % spectral FDR were re-introduced to the set of identified peptide spectral matches.  
The final FDR for the GG-tagged peptides retained using this method was < 5.7%. Proteins 
with at least one peptide with a lysine residue modified with glycinylglycine (GG-tag) were 
considered to be ubiquitinated. 
              Subcellular location and function assignments (relative to the parent cells) were 
made using the Protein Information Resource GO Slim (http://pir.georgetown.edu) using 
UniProt Gene Ontology annotations (12 2016). Pathway analysis was carried out using the 
canonical pathways from the REACTOME database.125 A pathway enrichment analysis of 
differentially abundant MDSC proteins was carried out using candidate protein-lists selected 
on the basis of significantly increased or decreased spectral counts, i.e. proteins with ratio of 
spectral counts (Rsc) ≥ 1 and Fisher's exact test FDR ≤ 5% (Benjamini-Hochberg multiple-




analysis was carried out on the ubiquitinated subset of INF and CON MDSC exosome 
proteins. The set of all identified MDSC exosome proteins was used as the pathway 
enrichment background for differentially abundant INF and CON proteins, while the set of all 
ubiquitinated MDSC exosome proteins was used as the pathway enrichment background for 
differentially abundant ubiquitinated INF and CON proteins. Fisher's exact test and 
Benjamini-Hochberg FDR, was used to assess the statistical significance of the number of 
proteins in common between each canonical pathway and the various candidate protein-lists 
versus the number expected, based on the background protein set.    
Spectral counting for identified proteins was carried out using in house software. The 
spectral count ratios (RSC) were generated by the method described in Old et al.127 The Fisher 
exact-test was used to generate p-values for differential spectral counts and Benjamini-
Hochberg FDR estimates were used to correct for multiple testing.126 
              Spectra of both ubiquitinated and non-ubiquitinated peptides were counted to assess 
ubiquitinated proteins in this bottom up study. The RSC is reported as the log2 ratio of INF vs 
CON exosomes.  
 
            3.2.4. Bioassay for MDSC Chemotaxis 
            As previously reported128  inflammatory MDSC (1x106) in 100 µL migration medium 
(IMDM supplemented with 3% fetal calf serum) were placed in the upper chamber of a 8.0µl 
transwell and either 500 µL of fresh medium, 500 µL of medium from cultured tumor cells 
(conditioned medium; positive control), exosomes, exosomes plus 3 µL polyclonal rabbit 
anti-ubiquitin antibody (ThermoFisher PA1-10023) or 3 µL of an irrelevant polyclonal rabbit 
antibody inactivated by heating at 56ºC for 30 min (Cederlane, Burlington NC) in the lower 




5% CO2.The number of MDSC migrating to the bottom chamber was quantified by 
hemocytometer. Values for each sample are the average results of triplicate samples and two 
independent hemocytometer counts per sample. 
Section 3.3 Results and Discussion 
3.3.1 Ubiquitinated proteoforms identified 
              Protein cargoes of exosomes derived from mice with low (CON) and high (INF) 
inflammation were examined using bottom-up mass spectrometry. In this study we have 
identified a total of 1188 proteins in MDSC exosomes.  More than 50% of the proteins 
identified from both conditions have ubiquitinated proteoforms. The INF MDSC exosome 
lysate identified 1092 proteins (Appendix 3.1), of which 589 had ubiquitinated proteoforms 
identified. A protein identified with a GG-modified peptide is one that can be said to have a 
ubiquitinated proteoform. The CON exosome lysate had 925 proteins identified, and 484 of 















(a)                                                             (b) 
Figure 3.2. Venn diagrams of the overlap between proteins in (a) overall proteins identified 
in CON and INF exosomes and (b) proteins with ubiquitinated proteoforms in CON and INF 
exosomes. 
The overlap between the proteins identified in INF and CON lysates is large, since 
90% of the proteins identified in the CON lysate and 76% of the proteins identified in the INF 
lysate are identified in both conditions (Figure 3.2a).  However, the overlap between the 
ubiquitinated proteins from the same exosome lysates is lower. Figure 3.2(b) shows that only 
69% of the Ub proteins identified in the CON lysate and 58% of the Ub proteins in the INF 
lysate are identified in exosomes from both conditions. A previous study also reported 
identifying 54 ubiquitinated proteins from MDSC exosomes using immunoprecipitation.44 
We have greatly expanded the number of ubiquitnated proteins identified by using the current 
strategy of not using enrichment and using the latest generation of Orbitrap mass 
spectrometers. It is interesting to note that the two strategies of identifying Ub proteins are 
complementary to each other and only identified 15 Ub proteins in common, and therefore 
the overall total number of Ub proteins in MDSC exosomes stands at 753.  
              Several other studies have also found exosomes to be carrying a highly 
ubiquitinated protein cargo.39,121 Huebner et al have reported 747 ubiquitinated peptides from 
593 proteins in urinary tract exosomes. Our study also finds Ub proteins with more than one 
site of ubiquitination. Overall, 737 ubiquitinated proteins were identified with 2322 sites of 
96 829 263 
   INF (1092) CON (925) 
Total proteins identified 
148 333 240 
INF (573) CON (481) 




attachment. More than 50% of these GG-modified tryptic peptides have the GG-modification 
located on the terminal lysine residue. The terminal GG-modification has been observed by 
several studies,39,44,55,129 and a mechanism for such a miscleavage has been proposed.130   
                  This study also confirms the presence of polyUb side chains in both CON and INF 
exosomes (Table 3.1).  Tryptic peptides from ubiquitin were identified with GG-addition on 
K-6, K-11, K-33, K-48 and K-63 residues. 
 
 





in    
MQIFVK(GG)TLTGK K-6 INF   
TLTGK(GG)TITLEVEPSDTIENVK K-11 INF CON 
IQDK(GG)EGIPPDQQR K-33 INF CON 
LIFAGK(GG)QLEDGR K-48 INF CON 
TLSDYNIQK(GG)ESTLHLVLR K-63 INF CON 
 
 
                To determine if ubiquitinated proteins present in MDSC exosomes are biologically 
functional, a migration assay was performed (Figure 3.3). The hypothesis was based on 
previous studies which demonstrated that MDSC derived exosomes facilitate the migration of 
parental MDSC.7,13,15 Migration was assessed by quantifying the number of parental MDSC 
that move via chemotaxis through a semi-permeable membrane toward a suspension of 
MDSC-derived exosomes.  Ubiquitin in exosomes was blocked using an anti-Ub antibody, 
and thus the effect of Ub on MDSC chemotaxis was ascertained. Conditioned media 
containing exosomes and soluble proteins (a positive control), or purified MDSC-derived 
exosomes promoted MDSC chemotaxis. However, when exosomes were incubated with anti-
Ub antibody, chemotaxis was decreased to a statistically significant extent.  Treatment of 




results suggest that apparent Ub molecules carried by MDSC-derived exosomes are involved 


























* Indicates values that are statistically different by at least p<0.004; Standard deviations 
are shown. Plot is from one of six independent experiments 
Figure 3.3. Assay for chemotactic activity in ubiquitinated proteins in exosomes shed by 
MDSC. MDSC were placed in the upper compartment of transwells and either tumor-
conditioned medium or MDSC-shed exosomes ± antibodies to ubiquitin was placed in the 
lower compartment. The number of MDSC migrating to the lower compartment was 





















































Previous studies have reported identifying the proinflammatory proteins S100A8 and 
S100A9 in MDSC exosomes.7 S100A8 and S100A9 have been shown to create an autocrine 
feedback loop, which results in sustained accumulation of MDSC. The S100A8 and S100A9 
in MDSC exosomes were shown to be biologically active and responsible for MDSC 
chemotaxis. In this study, S100A8 and S100A9 were identified in CON and INF MDSC 
exosomes with ubiquitinated proteoforms (Table 3.2). 
 
Table 3.2. GG-tagged peptides from proinflammatory cytokines identified in MDSC 
Accession 
No. 
Protein Peptide Peptide Spectral 
Matches (INF/CON) 




    8ALSNLIDVYHNYSNIQGNHHALYK(gg) 2/2 
    36K(gg)MVTTECPQFVQNINIENLFR 4/4 
    57ELDINSDNAINFEEFLAMVIK(gg)VGVASHK 3/0 




    37EFRQMVEAQLATFMK(gg) 1/2 
    54RNEALINDIMEDLDTNQDNQLSFEECMMLMAK(gg)L 23/14 
    88IFACHEK(gg)LHENNPR 1/0 
 
 
Proteomic studies performed on parental MDSC highlighted other proteins that had a 
role in the immunosuppressive functionality of MDSC.17 Chornoguz et al identified proteins 
involved with Fas-mediated apoptosis and the caspase network in MDSC lysates. INF MDSC 
was shown to be resistant to Fas-mediated apoptosis, which encourages their accumulation 
and thus increases their potency. Proteins caspase 3, caspase 8, lamin B1 and Rho GDP 
inhibitor beta which are associated with the Fas-pathway were identified in parental MDSC.17 
CON and INF MDSC exosomes in this study were also shown to carry proteins from the Fas-




proteins.  Further experiments are needed to determine whether MDSC exosomes are 
carrying a cargo that aids in enabling the INF MDSC to resist Fas-mediated apoptosis.  
         
      
3.3.2.The effect of inflammation on ubiquitination 
In this study we used label free spectral counting to examine the effect of 
inflammation on abundances of the ubiquitinated proteins in the MDSC- derived exosomes. 
The ubiquitome was compared to the total proteome and the proteins identified without an 
ubiquitinated peptide. Ratios of spectral counts (log2 [RSC INF/CON]) are summarized in 
Figure 3.4. All identified peptides (including GG-modified) were counted for all identified 
proteins. There were not enough GG-modified peptides identified to use spectral counting 
with statistical significance and draw conclusions about only the ubiquitinated proteoforms of 
the proteins identified. Therefore, these results can only be used to draw conclusions about 
the proteins at an overall level and we cannot distinguish the abundance of specifically the 
ubiquitinated proteoforms of identified proteins.  
The histograms in figure 3.4A and 3.4B show distributions of RSC which are similar 
for the ubiquitinated proteins and the non ubiquitinated proteins identified in the CON and 
INF exosomes. However, there is a small bias towards higher RSC in the non ubiquitinated 


















































Figure 3.4. Histograms of INF/CON ratios of spectral counts (log 2 Rsc) for (a) 753 proteins 
with ubiquitinated peptides in INF and CON exosomes; (b) 451 proteins for which no GG-
tagged peptides were identified. The dark blue and dark green histograms represent the 





























































 RSC ( Proteins not Ubiquitinated in exosomes) 
3.4A 
3.4B 
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To look further for effects of inflammation, gene ontology was used to compare 
ubiquitinated cohorts to each other, to the two exosome lysate inventories, and to the non-
ubiquitinated proteins. Subcellular location GO annotations (Figure 3.5) show little difference 
between ubiquitinated proteins in CON and INF samples, between these and proteins in the 
lysates, and also the non-ubiquitinated cohort of proteins.  
 
 
Figure 3.5. GO annotation comparisons of subcellular fractions of the INF and CON lysates, 
the ubiquitinated protein cohorts of two conditions, and the proteins identified without any 
Ub proteoforms.  
Pathway enrichment analysis was carried out using proteins identified in the INF and 
CON MDSC derived- exosomes. The 1188 proteins identified in CON and INF exosomes 
were used as the background protein-list, and proteins in the CON and INF exosomes were 
examined to find statistically increased, or decreased enriched pathways using Fisher's exact 
test at 10 % FDR. Nine pathways were found to be decreased in the INF cohort of proteins 
(or increased in CON exosomes) (Table 3.3). The pathways found to have a decreased 





















presence with an increase in inflammation, are all related to translation and RNA processing. 
However, no pathways were found to be increased in the INF cohort with statistical 
significance. A similar analysis was carried out on the ubiquitinated proteins identified in 
CON and INF exosomes, with the total 753 ubiquitinated proteins identified as the 
background. However, for this search, no pathways were found to be enriched with statistical 
significance. 
Table 3.3. Pathways with a significant decrease in proteins in response to INF. (Note: No 
pathways were found with a significant increase in response to INF)     
Pathway Description #Proteins found 
in CON 
#Proteins total in 
pathway 
FDR 




Nonsense Mediated Decay (NMD) independent of the Exon 
Junction Complex (EJC) 
8 95 1.12946
E-07 
Nonsense Mediated Decay (NMD) enhanced by the Exon 
Junction Complex (EJC) 
8 120 2.98042
E-07 
Formation of a pool of free 40S subunits 8 103 1.03459
E-06 




GTP hydrolysis and joining of the 60S ribosomal subunit 8 114 2.12839
E-06 




Translation initiation complex formation 6 59 2.89624
E-05 
Ribosomal scanning and start codon recognition 6 60 3.49053
E-05 
 
Hundreds of ubiquitinated proteins have been identified in MDSC derived exosomes. 
Other studies have reported identifying a large cargo of ubiquitinated proteins in 
exosomes.39,121 Also, the role of extracellular Ub in modulating immune responses has been 
reported. The next section will highlight enzymes identified in INF and CON exosomes that 
are involved in the Ub signaling system and could therefore shed light into possible roles of 









Three families of ubiquitin-utilizing enzymes have been identified in the protein 
lysates of CON and INF exosomes. The first family identified is enzymes involved in the 
ubiquitin- conjugating pathway (Table 3.4). Ubiquitin- activating enzyme E1 activates the 
conjugation of Ub in eukaryotic cells. Ubiquitin conjugating enzyme E2 N catalyzes the 
synthesis of poly-Ub chains that are linked through K63s and are implicated in the regulation 
of Toll-like, NOD-like, and RIG-l-like inflammatory pathways.115 Of the several hundred 
available E3 type ligases, four were identified in this study. One of these, E3 ubiquitin-
protein ligase UBR4 (A2AN08), is reported to form meshwork structures with clathrin (also 
identified in MDSC exosomes) and may be involved in invagination.131  
          Eight deubiquitinase enzymes were also identified in the lysate of INF and CON 
exosomes (Table 3.5). Ubiquitin terminal hydrolase 15 has been implicated in immune 
response modulation by the inactivation of T-cell responses. The relative abundances of Ub 
ligases and hydrolases are similar in INF and CON exosomes 
 
Table 3.4. Enzymes involved in the ubiquitin conjugation pathway. 
Accession 
No. 
Protein Distinct Spectral 
Counts  INF(-gg)* 
Distinct Spectral 
Counts  CON(-gg)* 
Q02053 Ubiquitin-activating enzyme E1  395(6) 286(3) 
P68037 Ubiquitin-conjugating enzyme E2 L3  32(0) 7(0) 
P61089 Ubiquitin-conjugating enzyme E2 N 6 3 
P22682 E3 ubiquitin-protein ligase CBL  1(1)  0 
A2AN08 E3 ubiquitin-protein ligase UBR4  13(6)  22(5) 
Q6PAV2 Probable E3 ubiquitin-protein ligase HERC4  4(1)  1 
O08759 Ubiquitin-protein ligase E3A  2(1)  0 
Q9D906 Ubiquitin-like modifier-activating enzyme 1 27(1) 30(2) 
Q8C7R4 Ubiquitin-like modifier-activating enzyme 6 2  1 







Table 3.5. Enzymes involved in hydrolysis of ubiquitin. 
Accession No. Protein Distinct Spectral 
Counts  INF(-gg*) 
Distinct Spectral 
Counts  CON(-gg*) 
Q9JMA1 Ubiquitin carboxyl-terminal hydrolase 14  25(2) 10(2) 
P70398 Probable ubiquitin carboxyl-terminal hydrolase 
FAF-X  
20(6) 35(2) 
P56399 Ubiquitin carboxyl-terminal hydrolase 5  27(2) 27(3) 
Q7TQI3 Ubiquitin thioesterase OTUB1  17 16 
Q6A4J8 Ubiquitin carboxyl-terminal hydrolase 7 56 36(1) 
Q8R5H1 Ubiquitin carboxyl-terminal hydrolase 15  5(3) 4(1) 
B1AY13 Ubiquitin carboxyl-terminal hydrolase 24 5(2) 6(3) 
Q9WUP7 Ubiqui tin carboxyl-terminal hydrolase isozyme 
L5 
 8 2 
* Entries in parenthesis indicate the number of GG-tagged peptides identified. 
 
The 26S proteasome is a protein family that hydrolyses Ub conjugates and has been 
identified in exosomes in other studies. Thirty-seven known subunits make up the murine 
proteasome and immunoproteasome. In this study we have identified 33 out of these 37 
subunits (Table 3.6). Six other proteomics studies have identified subunits of the 26S 
proteasome in exosomes derived from murine and human cells.39,42,132–135 Proteolytic activity 
of the 26S proteasome has been demonstrated in the lysate of exosomes derived from tumor 
associated macrophages and in the exosomes derived from mesenchymal stem cells.132,134 The 
proteasome has been shown to help regulate cytokine induction and to activate NF-κB, 















Table 3.6. Proteasome subunits identified and ratios of spectral counts calculated. 
Accession Protein Name Distinct Spectral Counts  
INF(-gg*) 
 Distinct Spectral 
Counts  CON (-gg*) 
Q3TXS7 26S proteasome non-ATPase regulatory subunit 1 125(29) 127(26) 
Q8BG32 26S proteasome non-ATPase regulatory subunit 11 55(1) 47 
Q9D8W5 26S proteasome non-ATPase regulatory subunit 12 28 62 
Q9WVJ2  26S proteasome non-ATPase regulatory subunit 13 73 42 
O35593 26S proteasome non-ATPase regulatory subunit 14 64(1) 61(3) 
Q8VDM4  26S proteasome non-ATPase regulatory subunit 2 250 213 
P14685  26S proteasome non-ATPase regulatory subunit 3 62 43 
O35226  26S proteasome non-ATPase regulatory subunit 4 1(1) 4 
Q8BJY1  26S proteasome non-ATPase regulatory subunit 5 26(2) 25(2) 
Q99JI4  26S proteasome non-ATPase regulatory subunit 6 60(1) 59(1) 
P26516  26S proteasome non-ATPase regulatory subunit 7 68 68 
Q9CX56  26S proteasome non-ATPase regulatory subunit 8 6(1) 8(3) 
P46471 26S protease regulatory subunit 7 50 51(1) 
P62192 26S protease regulatory subunit 4 22 57(2) 
P62334 26S protease regulatory subunit 10B 43 50(1) 
O88685 26S protease regulatory subunit 6A 77(2) 109 
P62196 26S protease regulatory subunit 8 37(2) 37(1) 
Q9R1P4  Proteasome subunit alpha type-1 101 64 
P49722  Proteasome subunit alpha type-2 198(3) 208 
O70435  Proteasome subunit alpha type-3 71 90 
Q9R1P0  Proteasome subunit alpha type-4 106(2) 37 
Q9Z2U1   Proteasome subunit alpha type-5 149(3) 105(3) 
Q9QUM9  Proteasome subunit alpha type-6 99(2) 117(3) 
Q9Z2U0  Proteasome subunit alpha type-7 120 84 
O09061  Proteasome subunit beta type-1 176(2) 144(1) 
Q9R1P3  Proteasome subunit beta type-2 143 89 
Q9R1P1  Proteasome subunit beta type-3 65(1) 66(1) 
P99026  Proteasome subunit beta type-4 138 136(1) 
O55234  Proteasome subunit beta type-5 37 22 
Q60692  Proteasome subunit beta type-6 96(1) 57(1) 
P70195  Proteasome subunit beta type-7 104(1) 57(1) 
O35955  Proteasome subunit beta type-10 22(1)  27 
P28063   Proteasome subunit beta type-8 84 72 
P28076  Proteasome subunit beta type-9 50(1) 32(1) 
† Italics indicate the subunit belongs uniquely to the immunoproteasome.  





The final ubiquitin-utilizing family identified in MDSC exosomes is proteins from 
the ATP glycolysis pathway (Table 3.7). This enzyme family has previously been identified 
in exosomes derived from mesenchymal stem cells and prostate cells.133,138 Exosomes from 
prostate cells have been confirmed to synthesize ATP.138 It could be possible that these 
enzymes in MDSC exosomes derive the ATP required for Ub conjugation.   
 
Table 3.7. Proteins identified from the ATP glycolysis pathway. 
Accession Protein Name Distinct Spectral Counts  
INF(-gg)* Distinct Spectral Counts  CON(-gg)* 
P16858 glyceraldehyde 3-phosphate dehydrogenase  800(1) 1273(2) 
P09411 phosphoglycerate kinase  219(3) 151(4) 
Q9DBJ1 phosphoglycerate mutase 133(1) 56(2) 
P17182 Enolase I aka alpha enolase 659(1) 920(2) 
P52480 pyruvate kinase 749(1) 1639(2) 
 
Section 3.4 Conclusions 
This bottom-up analysis of the protein cargo of MDSC-derived exosomes finds that 
more than 60% of the identified proteins contribute a ubiquitinated proteoform. Averages of 
three sites of ubiquitination are reported per protein identified.  The number of sites of 
ubiquitination per proteoform is not known, but could be determined by a follow-up top-
down mass spectrometry analysis of the protein cargo. Migration bioassays demonstrate that 





No significant differences were seen in the histogram distribution of Rsc values and 
subcellular GO annotations of ubiquitinated and non-ubiquitinated cohorts of proteins. The 
pathway enrichment analysis using REACTOME database was indicative of increased 
inflammation being independent of the ubiquitination in exosomes. It was found that an 
increase of inflammation leads to the decrease in proteins associated with translation and 
RNA processing in MDSC-derived exosomes. However, it remains unclear which pathways 
are enriched as inflammation is increased. Perhaps, the pathways involved are not yet 
annotated in the REACTOME database.  
The current study has identified proteins from the enzyme families E1, E2, and E3, 
which are required for ubiquitination. In addition, nine Ub-hydrolases have also been 
identified in INF and CON exosomes. The presence of enzymes for ATP synthesis, and a 
majority of the 26S proteasome have also been confirmed to be carried by the MDSC-derived 
exosomes. Studies by other labs have confirmed the intra-exosomal activity of the glycolytic 
enzymes and the 26S proteasome. The identification of these protein families leads to the 
hypothesis that ubiquitination is a modification which could be self-established in the MDSC-
derived exosomes. In summary, the MDSC-derived exosomes carry a large cohort of 
ubiquitinated proteins, and the machinery to generate the modification of ubiquitination 
within the MDSC-derived exosomes. It is currently not evident that an increased 
inflammatory environment has an effect on the ubiquitination observed in the MDSC-derived 










The ubiquitome of the MDSC exosomes has been interrogated using bottom-up mass 
spectrometry in Chapter 3 of this thesis. Our study reported that the MDSC-derived exosomes 
are hyperubiquitinated, as over 60% of the 1188 proteins were identified with GG-modified 
peptides. Also, ubiquitinated proteins were identified with an average of 3 sites of 
ubiquitination. While our bottom-up strategy provides insight into how many proteins are 
ubiquitinated and the site of ubiquitination on the substrate protein, it is limited in its ability 
to discern the topology of the ubiquitin chain on the substrate protein. Bottom-up proteomics 
is also limited in its ability to determine whether a protein has several sites of ubiquitination 
or whether there are several isoforms of the same protein with varied Ub linkage sites. 
 An alternative approach to bottom-up proteomics is the use of top-down proteomics 
to study ubiquitination. Top-down mass spectrometry involves the study of the protein 
without digesting it to form peptides. The whole protein is kept intact when introduced into 
the mass spectrometer, which allows the identification of post-translation modifications on 
the protein. Top-down proteomics has been established as a tool for discerning different 
linkages and topologies of polyubiquitin.53,54 Using the enhanced capabilities of ETD 
fragmentation on the orbitrap Fusion Lumos mass spectrometer, high sequence coverage of 
polyubiquitins has been achieved. Optimization of fragmentation conditions has led to being 




                  Our current study will extend these methods, which were developed on 
chemically, and enzymatically synthesized polyubiquitin dimers, trimers and tetramers, to 
find endogenous Ub conjugates in a complex biological sample. Since the MDSC-derived 
exosomes have been shown to carry over 700 proteins with ubiquitin proteoforms, they make 
a good candidate for the extension of the top-down strategy to characterize polyubiquitins.  
We hypothesize that using top-down mass spectrometry, polyubiquitin and ubiquitinated 
proteins will be identified and their linkage and topology can be determined in MDSC-
derived exosomes.  
                  Currently, top-down proteomics allows for characterization of proteins up to 30 
kDa in mass using an unmodified high-resolution orbitrap mass spectrometer.139 This means 
that Ub trimers (27 kDa) in a complex mixture of proteins can be easily detected. However, 
in order to detect Ub tetramers (34 kDa), a fractionated / simplified mixture of proteins will 
aid in the mass spectrometric identification. Ubiquitin conjugation provides a large mass 
change of 8.5 kDa. Therefore, monoubiquitinated proteins can have a maximum mass of 21.5 
kDa to be routinely detected using the orbitrap mass analyzer. For routine analysis of 
polyubiquinated proteins, the substrate protein can weigh a maximum of 13 kDa since the 
addition of a Ub dimer (17 kDa) will bring the total mass to 30kDa. In the current list of 776 
ubiquitinated proteins we have 69 proteins under 21.5 kDa, which would make good 
candidates for top-down characterization from the MDSC-derived exosomes (Table 4.1). It is 
possible that other proteins are also ubiquitinated in exosomes but were not identified in the 
bottom-up study. Peptides from the ubiquitin protein were identified with a GG-modification 
at lysine residues (Table 3.1), which indicates the presence of polyubiquitins in the MDSC-
exosome lysate. Other studies report that exosomes carry a cargo of mostly 




 In the current study MDSC-derived exosomes will be lysed and purification of Ub 
conjugates will be attempted. Proteins will be analyzed by a high-resolution orbitrap mass 
spectrometer, and class characteristic fragment ions from ubiquitin will be searched for in the 
reconstructed ion chromatogram. The raw data will also be analyzed using the bioinformatics 
platform Proteome Discoverer to identify ubiquitinated proteins.  
Table 4.1. Ubiquitinated proteins identified in bottom up analysis of exosomes which weigh 
less than 21.5 kDa without the ubiquitin side chain. 
 
Accession number Protein Name M.wt (Da) 
P62843 40S ribosomal protein S15 16908.91 
P63276 40S ribosomal protein S17 15392.89 
P47955 60S acidic ribosomal protein P1 11343.71 
P99027 60S acidic ribosomal protein P2 11650.91 
P35979 60S ribosomal protein L12 17804.56 
B1ATY1 Actin, cytoplasmic 2 16734.34 
Q9JM76 Actin-related protein 2/3 complex subunit 3 20393.49 
P59999 Actin-related protein 2/3 complex subunit 4 19535.82 
P11031 Activated RNA polymerase II transcriptional coactivator p15 14296.25 
P84078 ADP-ribosylation factor 1 20565.58 
P84084 ADP-ribosylation factor 5 20398.46 
P31230 Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 17989.88 
O54962 Barrier-to-autointegration factor 10102.59 
Q63810 Calcineurin subunit B type 1 19168.72 
P60766 Cell division control protein 42 homolog  20933.16 
P18760 Cofilin-1 18428.35 
P45591 Cofilin-2 18578.4 
P63242 Eukaryotic translation initiation factor 5A-1 16701.06 
P09528 Ferritin heavy chain 20935.41 
P09528 Ferritin heavy chain 21066.6 




Q9ERL7 Glia maturation factor gamma 16617.13 
Q61646 Haptoglobin precursor 9468.57 
Q9R257 Heme-binding protein 1 21066.85 
P01942 Hemoglobin subunit alpha 14953.98 
P02088 Hemoglobin subunit beta-1 15708.99 
P02089 Hemoglobin subunit beta-2 15747.06 
P15864 Histone H1.2 21135.46 
Q8CGP4 Histone H2A 14056.35 
C0HKE5 Histone H2A type 1-G 14004.3 
Q6GSS7 Histone H2A type 2-A 13964.3 
P0C0S6 Histone H2A.Z 13421.55 
P27661 Histone H2AX 15011.41 
P10854 Histone H2B type 1-M 13804.97 
Q8CGP0 Histone H2B type 3-B 13776.92 
F8WI35 Histone H3 15198.8 
P68433 Histone H3.1 15272.89 
P84228 Histone H3.2 15256.83 
P84244 Histone H3.3 15196.72 
P62806 Histone H4 11236.15 
A0A0A6YYE5 Immunoglobulin kappa variable 4-78  10348.47 
B2RV77 MCG130182, isoform CRA_a 10965.57 
Q6ZWQ9 MCG5400 19895.3 
P11247 Myeloperoxidase  13005.71 
Q60605 Myosin light polypeptide 6 16798.86 
Q3THE2 Myosin regulatory light chain 12B 19779.16 
Q9CQ19 Myosin regulatory light polypeptide 9 19723.02 
O08692 Neutrophilic granule protein  17141.98 
P09602 Non-histone chromosomal protein HMG-17 9291.5 
P24369 Peptidyl-prolyl cis-trans isomerase B 20218.15 




P0CG50 Polyubiquitin-C  8564.84 
P62962 Profilin-1 14826.02 
O54824 Pro-interleukin-16 12219.78 
P28076 Proteasome subunit beta type-9 21326.22 
Q99LX0 Protein DJ-1 precursor 19890.11 
P14069 Protein S100-A6 10050.62 
P27005 Protein S100-A8 10163.4 
P31725 Protein S100-A9 12917.67 
P63001 Ras-related C3 botulinum toxin substrate 1 21110.63 
P84096 Rho-related GTP-binding protein RhoG 20969.03 
Q99KH8 Serine/threonine-protein kinase 24 12699.31 
Q9JI10 Serine/threonine-protein kinase 3 20367.52 
Q9JI11 Serine/threonine-protein kinase 4 18458.7 
P62315 Small nuclear ribonucleoprotein Sm D1 13281.57 
P62320 Small nuclear ribonucleoprotein Sm D3 13785.05 
Q9ESP1 Stromal cell-derived factor 2-like protein 1 20899.07 
P10639 Thioredoxin 11544.25 












             4.2.1. Myeloid-Derived Suppressor Cells and Exosome harvesting 
             
Female BALB/c mice, 6-10 weeks of age (bred in the UMBC animal facility from 
breeding pairs obtained from The Jackson Laboratory, Bar Harbor, ME), were injected in the 
mammary fat pad with 7000 4T1 cells transfected with the IL-1β gene (4T1/IL-1β) cells. 
Mice were bled from the submandibular vein when tumors were greater than 8mm in 
diameter. MDSC were harvested from the blood, labeled with fluorescently coupled 
antibodies to MDSC markers, and assessed by flow cytometry (Beckman/Coulter Cyan ADP) 
for purity.7,17 Cell populations that were >90% pure Gr1+CD11b+ cells were used in these 
studies.  Approximately 108 MDSC were obtained from 2-3 mice. Following isolation from 
mice, MDSC were maintained in serum-free HL-1 media overnight at 37°C to collect 
exosomes. 20. After 18 hr each supernatant containing exosomes was centrifuged at 805xg 
and 2090xg to remove residual cells and then ultracentrifuged at 100,000xg to pellet the 
exosomes. Pellets containing the exosomes were resuspended in PBS and they were stored at 












                4.2.2. Ubiquitin proteome enrichment using Tandem Ubiquitin Binding Entities  
               (TUBES)   
                Exosomes from 1.6x108 cells were thawed and lysed in TUBES lysis buffer (50 
mM Tris-HCl, 0.15 M NaCl, 1 mM EDTA, 1 % Nonidet P-40, 10 % glycerol, pH 7.5),        
50 µM  deubiquitinase inhibitor PR-619 (LifeSensors, Malvern, PA),  15 µM of 
deubiquitinase inhibitor MG-132 (Enzo Life Sciences), 10 mM N-ethylmaleimide (Sigma-
Aldrich, St. Louis, MO) and 1% of a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, 
MO). The lysates were centrifuged at 14 000xg for 30 min with a 3 kDa molecular weight cut 
off filter, and the filtrates were discarded. This process was repeated three times. After lysis 
of exosomes the buffer was diluted and concentrated in 50 mM ammonium bicarbonate. 
Protein was collected by inverting the filters and centrifuging at 1000xg for 2 min. Protein 
content before and after TUBES isolation was measured by the Quick Start Bradford Assay 
(BioRad, Hercules, CA). The protein lysate was incubated in a spin column (Thermo Fisher 
Scientist, Waltham, MA) with uncoupled agarose for 30 min at 4°C on a rotator. Agarose 
TUBES II (100 µl of a 50% slurry)( LifeSensors, Malvern, PA) was added to Poly-prep 
columns (Bio-Rad, Hercules, CA) and washed three times Tris buffered saline with  Tween 
(TBS-T). The cleared exosome protein lysate was added to the slurry of agarose-TUBEs II. 
The TUBES-II and exosome lysate was incubated overnight on a rotator at 4°C. The non-
bound proteins were collected and the resins were washed 3x with TUBES lysis buffer. 
Ubiquitinated proteins were eluted by shaking for 5 min on shaker with 2 bead volumes of 1 
M NaCl (2x) and 0.2 M glycine pH 2.5 (6x), and with 2 % SDS (2x). The eluted proteins 
were then desalted with C4 zip-tips (EMD Millipore, Billerica, MA) according to the 
manufacturer’s protocol.  
 






 4.2.3. Immunoprecipitation of Ubiquitinated Proteins Using FK2 Antibody 
                 Exosomes from 2x109 cells were lysed with RIPA buffer (PBS containing 1% 
Nonidet P-40, 0.5 % sodium deoxycholate, 0.1 % SDS), 50 µM  deubiquitinase inhibitor PR-
619 (LifeSensors, Malvern, PA),  15 µM of deubiquitinase inhibitor MG-132 (Enzo Life 
Sciences), 10 mM N-ethylmaleimide (Sigma-Aldrich, St. Louis, MO) and 1% of a protease 
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). They were centrifuged at 14, 000xg for 30 
min with a 3 kDa molecular weight cut off filter, and the supernatants were discarded. This 
process was repeated three times. After lysis, the buffer was diluted to 0.8 M urea in 50 mM 
ammonium bicarbonate. Protein was collected by inverting the filters and centrifuging at 
1000xg for 2 mins. Protein content before and after FK2 immunoprecipitation was measured 
by the Quick Start Bradford Assay (BioRad, Hercules, CA). 
                The exosome protein lysate was pre-incubated with control agarose for 1 hour at 
4°C on a rotator. The non-bound flow through was collected and incubated with 30 µg of 
immobilized FK2 antibody. The anti-Ub FK2 antibody (Enzo Lifesciences, Farmingdale, 
NY) was bound to protein A/G and agarose according to directions provided in the Pierce 
Crosslink Immunoprecipitation kit column (Thermo Fisher Scientist, Waltham, MA). The 
precleared lysate and FK2 antibody was incubated overnight on a rotator at 4°C. The non-
bound fractions were collected by washing 4x with 10 bead volumes of RIPA buffer. Bound 
ubiquitinated proteins were eluted from the FK2 antibody using three elution methods- 8M 
urea buffer (8 M urea, 300 mM NaCl, 50 mM Na2HPO4, 0.5 % NP-40, pH 8), 2 % SDS and 
0.1 % glycine (pH 2). The proteins were incubated with each elution buffer for 5 min on 
shaker, and then collected by centrifugation 1000xg, 1min at room temperature. This was 
repeated 3x for each elution buffer.  






4.2.3.1.Western Blot Analysis 
              Fractions collected from each step of the FK2-antibody immunoprecipitation were 
subjected to one-dimensional gel electrophoresis on an 8−16% Criterion precast gel (Bio-
Rad, Hercules, CA) at 200 V, 50 mA, and 15 W for 45 min. One-third of each of the fractions 
collected were run on the gel. Gel electrophoresis was followed by transfer of the proteins to 
a PVDF membrane (EMD Millipore, Billerica, MA) at 100 V, 250 mA, and 25W for 50 min. 
Ubiquitin and ubiquitinated proteins were detected by blotting with primary anti-ubiquitin 
antibody FK2, followed by anti-mouse IgG-HRP (Cell Signaling Technology). Protein bands 
were visualized using SuperSignal West Dura chemiluminescent substrate (Thermo Fisher 
Scientific, Waltham, MA) with an Image Lab System (Bio-Rad, Hercules, CA) and  Gel-Doc 
program (Kodak Molecular Imaging Systems).  
4.2.4. Exosome Ubiquitome Analysis Without Enrichment 
                  Exosomes from 4.9x108 cells were thawed and lysed in 8 M urea in 50 mM 
Ammonium bicarbonate with 15 µM of deubiquitinase inhibitor MG-132. They were 
centrifuged at 14 000xg for 30 min with a 3 kDa molecular weight cut off filter, and the 
supernatants were discarded. This process was repeated three times. After lysis, the buffer 
was diluted to 0.8 M Urea using 50 mM ammonium bicarbonate in the 3 kDa molecular 
weight cut off filter. Protein was collected by inverting the filters and centrifuging at 1000g 
for 2 min. Protein content was measured by the Quick Start Bradford Assay. Proteins were 
reduced using 10mM TCEP in 0.1 % acetic acid (pH 2) for 15 min at 60 °C. The same lysate 
was also used for an experiment where different concentrations of K-48 linked linear Ub 
trimer (Boston Biochemical Inc, Cambridge, MA) were spiked into the lysate, followed by 




(10 ng trimer in 1µg of lysate), 2.5% (25 ng trimer in 1µg of lysate), 5% (50 ng trimer in 1µg 
of lysate), and 20% (200 ng in 1µg of lysate).  
 
  4.2.4.1. Liquid Chromatography Mass Spectrometry Analysis 
  Exosome protein lysates (without enrichment) were analyzed using an Ultimate 3000 
RSLC nano ultra-high performance liquid chromatograph (Dionex, Sunnyvale, CA). The LC 
was used in line with the orbitrap Fusion Lumos mass spectrometer (Thermo Fisher 
Scientific, Waltham, MA). Exosome lysates were desalted and concentrated in a PepSwift 
RP-4H monolith trap (100 µm × 5 mm) and then separated using a ProSwift RP-4H monolith 
column (200 µm × 25 cm). Proteins were then separated using a linear gradient from 1−55% 
B (97.5% acetonitrile, 0.01% formic acid) for 145 min, where solution A is 97.5 % water, 
0.01 % formic acid. For some analyses, proteins were desalted and concentrated at 20 % 
solution  B, and separated using a linear gradient from 20-55 % B for 145 min. The mass 
spectrometer was optimized for intact protein analysis in which the ion routing multipole 
pressure was maintained at 3 mTorr. Precursor and product ions were analyzed in the orbitrap 
with mass resolution 120,000. The “Top-speed” data-dependent mode was selected for 
precursor ions fragmentation in which a maximum number of abundant precursors are 
isolated by the quadrupole in a fixed duty cycle time of 10s. Precursor ions with a charge 
state +8 or higher were selected for fragmentation, and precursors with an undetermined 
charge state were included too. Dynamic exclusion was set to 60 s for this analysis. The 
fragmentation technique used was EThcD with a reaction time of 6 ms for electron transfer 
dissociation (ETD) and 10% supplemental higher collision energy (HCD). Three microscans 
were averaged for each spectrum generated. Automatic gain control targets were set to 1 × 










Data processing was performed using the Prosight node v. 1.1 in the Proteome 
Discoverer v.2.1 suite (Thermo Scientific, San Jose). Each raw data file was searched against 
the Mus musculus database downloaded from the Uniprot database (June 2017). The searches 
were performed with the following parameters: precursor mass tolerance 40,000 Da, fragment 
mass tolerance 10 ppm, precursor m/z tolerance of 0.2, max retention time difference 0.5 min, 
precursor and fragment S/N threshold of 3. The target decoy peptide spectrum match (PSM) 
validator was used with a maximum delta correlation of 0.05. Only PSMs reported with a 
high confidence Xcorr score were retained in this study. Prosight Lite was used to view the 
MS/MS ions identified for the proteins,141 with a fragment tolerance of 10 ppm. Xcalibur 
v.2.1. was used to view the raw data and generate extracted ion chromatograms.  
4.3. Results 
4.3.1. TUBES Ubiquitin enrichment 
             The goal in this study was to isolate endogenous ubiquitinated proteins from MDSC-
derived exosomes and analyze the proteins using top-down mass spectrometry. Three 
different approaches were evaluated and optimized to this end: (1) agarose-TUBES, (2) anti-
Ub antibody FK2, and (3) top-down investigation of non-fractionated exosome lysate. 
Agarose-TUBES are based on high affinity Ub binding domains which specifically bind to 
polyUb conjugates.142 As a proof of concept, agarose-TUBES II (which has an equal affinity 




linear polyUb chains of different lengths (courtesy of Dulith Abyekoon in the laboratory of 











Figure 4.1.  One-dimensional silver stained gel that depicts the different fractions collected 
from the agarose-TUBES II enrichment of 10µg of a standard poly Ub mix. 
 
The experiment confirmed the successful use of agarose-TUBES to enrich polyUb 
conjugates. Lane 2 (Figure 4.1) is the standard polyUb mix run on the gel (without incubation 
with agarose-TUBES II). Lane 7 is elution of the poly Ub mix post agarose-TUBES II 
enrichment. The lowest band observed in lane 2 which corresponds to monoUb, was not 
observed in the lane 7. This is an indication of the specificity of agarose-TUBES II for 
polyUb conjugates. However, agarose-TUBES II polyUb enrichment from protein in lysates 


















































































Figure 4.2. One-dimensional silver stained gel which depicts the different fractions collected 
from the agarose-TUBES II enrichment of protein lysate from MDSC-derived exosome.  
 
 A band at around 10kDa is observed in the lanes 2-8 in the silver stained gel (Figure 
4.2). This mass is too low to be a polyUb protein and is therefore indicative of carryover from 
the wash steps. No other bands at higher masses were observed from the elution fraction. 
There are two possibilities for this result- 1. Most proteins in exosomes may exhibit mono 
ubiquitination or multiple mono ubiquitination, and therefore the agarose TUBES did not 
enrich the Ub protein conjugates. 2. We may need a higher amount of starting material. 
Schwertman et al performed a successful purification of polyUb conjugates from HeLa and 
XP2OS cells using agarose-TUBES.142 However, Schwertman et al used 5.3 mg of protein 
lysate from cultured cells whereas this study has limited starting material of ~150 µg from 
each batch of purified exosomes. Therefore, a second strategy of using anti-Ub antibody FK2 

































































4.3.2. Immunoprecipitation using FK2 antibody 
           The anti-Ub FK2 antibody was chosen for its ability to enrich mono- and polyUb 
conjugates. Schertmann et al. had described a detailed optimized protocol for 
immunoprecipitation using anti-Ub FK2 from cells, which was used in this study.142 Fractions 
were collected from each step of the immunoprecipitation experiment and were fractionated 
on a one-dimensional gel followed by western blot analysis for Ub (Figure 4.3). The gel had 
two bands in elution lane 9 at masses 25kDa and 50kDa. While the bands could be indicative 
of ubiquitinated proteins, it could also be the heavy and light chain on the antibody, since 
crosslinking of antibody to beads was not performed. Crosslinking of FK2 antibody has been 
shown to disrupt the antibodies ability to bind to Ub conjugates.142 A light band at 75kDa was 
also observed, but at that mass, a top-down mass spectrometry analysis is not possible. The 
western blot analysis, performed with an anti-Ub antibody FK2, (Figure 4.3 b), showed bands 
below 25kDa in the flowthrough sample. This is indicative of the FK2 antibody 
immunoprecipitation not working, and the FK2 antibody not recognizing the Ub conjugates. 
Therefore, a strategy without purification of the Ub conjugates was attempted, even though 


















































































































































Figure 4.3. Fractions collected from the immunoprecipitation using the anti-Ub FK2 
antibody run on. a one-dimensional gel, silver stained. B. run on a one dimensional gel 
followed by a western blot against Ub.  
 
        
   4.3.3. Top down analysis of exosome proteins 
The protein cargo of exosomes was analyzed using top-down mass spectrometry 
without any enrichment of Ub conjugates or fractionation of the lysate. The precursor 
tolerance window was expanded to 40 kDa, using the bioinformatics program Prosight PD. A 
wide tolerance for the mass of the precursor ions would allow for the identification of 
polyubiquitin with a large addition of mass, which would occur if it were conjugated to a 
protein. Monoubiquitin was identified in the exosome lysate eluting at 74 min (Figure 4.4). 
Studies by Lee et al have shown the occurrence of fragmentation in the first 18 residues of Ub 
in top-down studies of synthetic Ub.53 In our current study, fragmentation of the endogenous 
monoUb from exosomes is shown in Figure 4.5, which confirms the fragmentation of 
residues 1-18, as 9 out of the possible 18 c-ions are observed. 
Figure 4.4 shows the extracted ion chromatogram for the precursor mass of monoUb 
followed by extracted ion chromatograms for expected product ions for c ions expected from 
the N-terminus of the monoUb. These ions are termed as the class characteristic ions of 
ubiquitin. Since ubiquitin can either attach from its lysine residues to other Ub or through its 
C-terminal residues to other substrate protein, the c/b-ions from the first 18 residues will be 
deterministic of the presence of ubiquitin. Ubiquitin conjugated to a substrate protein will not 
have the expected precursor mass of either Ub or the attached protein; therefore, looking for 
the class characteristic c-ions is a preliminary indicator of possible Ub conjugates. In our 
current top-down investigation of MDSC-derived exosomes, a series of class characteristic c- 
or b-ions was not observed at other retention times. Therefore, polyUb or Ub conjugated 
proteins have not been identified in exosomes using top-down mass spectrometry thus far 




















Figure 4.4. Reconstructed ion chromatogram (RIC) for exosome protein lysate top-down analysis 
and extracted ion chromatograms (XIC) for the monoisotopic mass of Ub (8559.62), and XIC of 












XIC 535.78 (c-5) 
XIC 634.85 (c-6) 
XIC 762.94 (c-7) 
XIC 863.99 (c-8) 
XIC 977.08 (c-9) 
XIC 1079.12 (c-10) 




            
Figure 4.5. Sequence of a monoUb with c-, b-, y- and z-ions identified from the top-down 
analysis. The c- and z- ions are depicted by red carats and the b- and y-ions are depicted by 
blue carats.  
 
The raw data for the top-down analysis of Ub exosomes was also processed using the 
Prosight software node in Proteome Discoverer with a wide window for precursor mass 
tolerance (40,000Da). This would allow us to identify proteins at unexpected masses, which 
would be the case with a protein with ubiquitin attached to it.  A total of 29 proteins were 
identified based on fragmentation using top-down mass spectrometry from the MDSC-
derived exosomes (Table 4.2). Forty-four percent of the proteins identified were from the 
histone family. The proteins highlighted in grey in Table 4.2 correspond to proteins also 
identified from the bottom-up analysis, which were listed in Table 4.1. Comparing the two 
tables shows that top-down and bottom-up are complementary approaches of analyzing a 
protein mixture. The top-down analysis yielded the identification of several histones, which 
were not identified in the bottom-up analysis and vice versa. 
              Most proteins identified were not identified at their expected molecular weights, but 
identified with smaller molecular weights. The only proteins identified at their expected 
molecular weights were ubiquitin, S100A8, and CDNA sequence BC100530 (an un-reviewed 
entry on Uniprot) (Appendix 4.1). Therefore, we conclude that exosomes are carrying many 
truncated proteins amongst their cargo of functional proteins. Ubiquitin was not identified 
with an increase in mass, which would have led to the possibility of identifying a Ub 






Table 4.2. Proteins identified in the top-down analysis of MDSC-derived exosomes. The 
proteins highlighted in grey were also identified in the bottom-up analysis and weighed less 



































An experiment with linear K-48 linked Ub trimer spiked into the MDSC-exosome 
lysate was performed. The standard was added at the following increasing concentrations- 




to check the signal intensity of a polyUb at different concentrations in a complex protein 
lysate, since we were concerned about the lack of evidence of Ub conjugates using top-down 
mass spectrometry.  The results in Figure 4.6 indicate that even at low levels of unanchored 
polyUb, our instrument and methods employed for the LC-MS/MS analysis are successful at 
identifying the mass of Ub trimer. It is also apparent that with increasing concentration of Ub 
trimer in the MDSC-exosome lysate, the normalized signal intensity (NL) also increases 
(Figure 4.6). However, good fragmentation is required to make identifications based on class 
characteristic ions and Prosight PD. Figure 4.7 shows the fragmentation patterns for the Ub 
trimer added in various concentrations. Even though molecular ions for the Ub trimer could 
be detected at 1% concentration, the fragment ions are not strong enough to identify the 
precursor as a Ub trimer. At 2.5% and 5% only one fragment (b- and c-ions 218) shows proof 
of polyUb. It is not until we get to 20% concentration of polyUb in the exosome lysate that 











Figure 4.6. Extracted ion chromatograms of mass-25657.50 Da from the spike in experiments at 

































Figure 4.7. Fragment c-,z-,b- and y-ions identified from K-48 linked linear Ub trimer spike-in 





















4.4. Conclusions  
  Purification techniques used to enrich for Ub conjugate from the protein lysates of 
MDSC-derived exosomes were not successful. The agarose-TUBES were specific for poly-
Ub conjugates and unanchored polyUb, and perhaps the MDSC exosomes do carry a higher 
concentration of monoUb and multiple mono-Ub conjugates.  The anti-Ub FK2 antibody was 
not successful in isolating Ub conjugated proteins as evidenced by bands observed in western 
blots of the flow through fraction of the immunoprecipitation experiment. Finally, the top-
down analysis of the non-enriched lysate of MDSC-derived exosomes identified mono-Ub 
but failed to identify unanchored polyUb or Ub conjugated proteins. This could be a result of 
the exosomes carrying long chains of polyUb or multiple mono-Ub conjugates, which will 
not be in the detectable mass range of the mass spectrometer. This hypothesis is validated by 
the finding that a large concentration of a polyUb trimer (26 kDa) is required for acquiring 
fragmentation to confirm the presence of a trimer. It is unrealistic to expect a polyUb 
conjugate to make up 20% of the total protein concentration, as would be required for 
identification of a polyUb. Therefore, in order for the strategy involving class characteristic 
ion fragmentation to work, narrower, and higher HPLC peaks will be required. Also, with our 
current capabilities, 200 ng of a polyUb trimer will be required for attaining fragmentation to 
discern the presence of a Ub trimer. The same holds true for the identification of polyUb 













Chapter 5:  Conclusions and future prospectus  
 
Myeloid derived suppressor cells (MDSC) are immunosuppressive cells present in 
most cancer patients.143 These cells are known to release exosomes into the tumor 
microenvironment, and these exosomes have been found to contain biologically active 
molecules.7,19,128 The presence of MDSC in the body leads to suppression of adaptive and 
innate immune responses, and poses a hurdle for successful immunotherapy. The exosomes 
shed by MDSC have also been shown to carry proteins that  use chemotactic activity to lead 
to the accumulation of the parental cells, which increases the potency of the 
immunosuppressive function.7,128  
The work presented in this thesis focuses on interrogating the protein cargo carried 
by the MDSC derived exosomes, in an effort to gain insights on the mechanisms of their 
immune suppression and intercellular communication. Post-translational modifications can 
determine protein function and cellular interactions. Therefore, this study exploited PTM’s to 
enrich proteins carried by MDSC exosomes that may be lower in abundance or difficult to 
identify in a shotgun proteomic approach. 
First, a method to identify exosomal surface glycoproteins was successfully 
employed. It was determined that the surface of the exosomes closely resembles that of the 
parental cells. Many of the identified surface molecules on the exosomes had the potential to 
regulate activity and function of the parental cells. Amongst these molecules the strongest 
case was made for CD47, as it was demonstrated that exosomal CD47 enhanced the 
accumulation of the MDSC, thereby increasing immunosuppressive activity. 
The second objective was to interrogate the PTM of ubiquitination using bottom-up 
proteomics. It was determined that the exosomes were carrying a highly ubiquitinated cargo 




MDSC derived exosomes can play a role in MDSC chemotaxis. The presence of enzymes 
involved in the conjugation of Ub, and enzymes involved in the production of ATP, led to the 
hypothesis that ubiquitination could occur in situ in MDSC- derived exosomes.  
Exosome cargo was also examined using a top-down proteomic strategy, which 
revealed that many proteins are present in multiple truncated proteoforms. This is consistent 
with an older idea that exosomes remove “junk” cellular debris (including proteins) from 
cells. It is also consistent that proteasome activity has been demonstrated in exosomes. No 
ubiquitinated conjugates were characterized, but it is possible that they are larger than 30kDa, 
which is the current limit of detection of top-down mass spectrometry.  
Future biological assays on proteins identified on the surface and also on selected 
ubiquitin conjugates would continue to define the biological relevance of the protein cargo. 
The studies performed in this thesis homed in on the effects of the exosomal protein cargo on 
the parental cells.144 However, it would be of interest to test the role of MDSC-exosomal 
surface proteins in communicating with other cellular players in the complex tumor 
microenvironment. The top-down strategy to evaluate ubiquitinated protein cargo has great 
potential for future development. Implementing a successful strategy to fractionate the 
exosomal protein cargo, with sharper peaks in liquid chromatography time-scale would help 
in identification of larger ubiquitinated protein complexes. Optimization of the fragmentation 
method used in the mass spectrometer would also be required. Also, bioinformatics software 
currently does not have the capability to identify truncated ubiquitinated proteins. The lack of 
bioinformatics tools will be a challenge since many truncated proteins were identified in the 
exosomal cargo. However, with optimized MS2 fragmentation, characteristic b-ions can be 
used to recognize and short-list precursor ions of ubiquinated proteins. The spectra identified 
could then be interpreted using a combination of bioinformatics tools such as Prosight PC and 
Prosight PD.  
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